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ABSTRACT 
Cardiovascular disease (CVD) such as coronary heart disease (CHD) is a contributing factor to a 
large percentage of mortalities and morbidities worldwide including in affluent South African 
setting. In the Eastern Cape of Province, South Africa, there is no extensive data reported on 
Coronary Heart Disease (CHD) determinants and risk factors. The present study sought to assess 
the risk factors and determinants of CHD.  
This case (n=50) control (n=50) study matched for sex and age, was conducted among Xhosa 
adults from rural and semi urban/ township areas of Joe Gqabi District, Eastern Cape Province of 
South Africa.  Non modifiable, environmental, lifestyle, and psychological factors were 
investigated using univariate analysis and multivariate logistic regression analysis.  
Depression, alcohol excessive intake, family history of CHD were the CHD univariate risk factors. 
The independent risk factors of CHD were uncontrolled systolic hypertension (Odds Ratio 
(OR)=95; 95% Confidence Interval 16.9-128; P< 0.0001), personal history of hypertension 
(OR=72; 95% CI 15.8-328; P<0.0001), married (OR=6.7;95% Confidence Interval 2.2-20.9; 
P<0.001), personal history, of diabetes mellitus (OR=6.3; 95% CI 1.1-42.4; P=0.049), no intake 
of fibre (OR=3.6;95% CI 1.1-12.8; P=0.049), semi urban/township (OR= 6.5; 95% Confidence 
Interval 2-20.5; P=0.002), and severe overall obesity (OR=5.8; 95% CI 1.5-22.4; P=0.011). 
In front of a multifactorial disease driven by interactions of socio determinants and traditional 
risk factors, urgent programmes of education, clinical management and health promotion for 
adequate diet, physical activity, adherence and compliance to medication and are needed to curb 
epidemic proportions of CVD risk factors. 
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CHAPTER 1: ORIENTATION AND OVERVIEW OF THE STUDY 
1.1 INTRODUCTION 
Globally, cardiovascular disease (CVD) has to date been labelled as among the main 
causes of death and has claimed an estimate of 17 million lives, it is no longer just a 
problem of industrialized world as previously labelled (WHO, 2011). Maredza, et al. 
(2011) published that the South African burden of CVD was rapidly escalating amongst 
all age groups, race, gender and was predicted to become the prime contributor to 
overall morbidity and mortality in the over fifty (50) year age group (Maredza, et 
al.,2011). 
Cardiovascular disease have been defined as disease which encompass conditions or 
disorders of the heart and referred to as “any disease of the heart and blood vessels”, 
the most common ones are diseases of the heart muscle, strokes, heart attacks, heart 
failure and heart disease” (Steyn, 2007).   
 
In 2011, the World Health Organization published the prevalence of CVDs on the 
prioritized research agenda for prevention and control on non communicable disease 
among countries, by highlighting the significant burden among high income countries 
and low middle income countries. The latest evidence shows that nearly 85% of the 
global mortality and disease burden from CVD is borne by low- and middle-income 
countries (LMIC). The increase in CVD burden in LMIC has largely been the result of 
the rapid economic transition; urbanisation (which may be due to people leaving their 
rural home in search for a better life), industrialisation and globalisation, thus bringing 
about lifestyle changes which stimulate heart diseases (WHO, 2011). 
 
1.2 THE WORLD IN TRANSITION: IMPLICATIONS FOR CARDIOVASCULAR 
DISEASE 
1.2.1 Epidemiological Transition 
The substantial increase on cardiovascular disease related mortalities and morbidity 
within LMIC and High Income Countries is part of the broader concept dubbed as 
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“epidemiological transition”, which was recorded by Olshansky and Pearson (Mbewu, et 
al., 2006).  
In 1994, a journal article by Mackenbach described epidemiological transition as the 
historical development of mortality overtime and which is characterized by three 
phases, namely, “Age of pestilence and famine, Age of receding pandemics, and the 
Age of degenerative and man-made diseases”, this was a transition from a cause of 
death pattern dominated by infectious diseases with a very high mortality, especially at 
younger ages to a pattern dominated by chronic diseases and injuries (Mackenbach, 
1994). Epidemiologic transition provided a potentially powerful framework for the study 
of disease and mortality in populations and its primary purpose is to describe and 
explain the spectacular fall in mortality which has occurred in all industrialized countries 
and can be used to speculate future changes in mortality in countries which are lagging 
behind to those which have already completed the epidemiologic transition 
(Mackenbach, 1994).  
 
 Fourteen years later in 2009, Mbewu described the epidemiological transition as the 
transition that comprises of four stages which are “Age of pestilence and famine, Age 
of receding pandemics, Age of degenerative and man-made diseases, and Age of 
delayed degenerative diseases.” This transition is mainly fuelled by rapid changes in 
demographics which include the declining rate of infant and child mortality resulting in 
large increases in the number of individuals who survive until middle and older age 
(Mbewu, 2009). Secondly, a major decrease in the number of communicable disease 
related death rates due to improved immunizations, maternal health, nutrition 
programs and socio economic development, however in the same breath the socio 
economic changes have resulted in environmental and behavioural determinants of 
CVD such as but not limited to: tobacco use, physical inactivity, increase in fatty food 
consumption (Mbewu, 2009).  
 
Lessons learnt from the Heart of Soweto Study by Pretorius, et al. (2011) affirms the 
statements by Mbewu, at which they stated that South Africa is concurrently 
experiencing epidemiological transition with diseases of lifestyle on the increase, while 
still being burdened by poverty related diseases as well. The socio-economic status and 
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development of a country have a direct impact on the mortality and morbidity of its 
people.  
(Luepker, 2012) reviewed on the implications of CVD on the epidemiological and 
demographic transition as the health trajectory at which cardiovascular diseases are 
becoming the leading causes of morbidity and mortality among adults in both 
industrialized and developing world. Historically, the peak and decline of the CVD 
epidemic in the 1960s and 1970s in some countries was not well recognized, which 
lead to calls for more population-based disease surveillance. The Framingham study 
and the WHO Multinational MONItoring of Trends and Determinants in CArdiovascular 
Disease (MONICA) Project were the most comprehensive approach to better 
understanding disease transition, etiology, incidence and trends at the population level 
(Leupker, 2012). 
 
1.2.2 Demographic Transition 
In recent years Africa, in particular the Sub Saharan Region has undergone 
demographic transition which resulted in the epidemiological transition. Mbewu, et al. 
(2006) clarifies this transition as a transition marked by a rapid shift in population 
mortalities from infancy to adulthood, where there has been evident decline in infant 
and child mortalities thus resulting in the number of individuals surviving until middle 
and older age. Declining mortality rates are a result of improved public health care 
which is accompanied by socio economic development, improved vaccination and 
improved Primary Health Care services (Mbewu, et al., 2006).  
 
In South Africa (SA) when the African National Congress (ANC) led government came 
into power in 1994 a national health plan was developed which focused on key priority 
programmes (maternal and child health, nutrition, the control of communicable 
disease, violence and special attention to vulnerable groups such as programmes for 
women’s health, rural areas, chronic illnesses) and to provide targets for implementing 
changes to the current health system (national Health Policy, 1994). This crucial health 
policy development positively influenced the shift in geographical distribution of health 
care and the patterns of internal and international migration thus resulting in 
epidemiological transition (National Health Policy, 1994). 
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1.2.3 Economic, Social and Nutritional transition 
These transitions are marked fundamental changes in the main determinants of health 
and seem to indicate the point in economic development at which the vast majority of 
the population gained reliable access to the basic material necessities of life. As the 
country improved on policies (National Planning Commission: National Development 
Plan Vison 2030, 10 point plan) and health care services over the years in addressing 
communicable diseases, the occurrence of chronic non communicable diseases still 
continued to escalate leaving the country in an alarming state of vulnerability.  
 
Among the total South African population, there are 800 deaths per 100 000 as a result 
of cardiovascular disease and in every 10 minutes one South African dies from a 
cardiovascular related disease (Anand, et al., 2008) The Heart of Soweto Study in 
Pretorius, et al. (2011) suggest that data on the population of Soweto has shown a low 
prevalence for CVD and the underlying risk factors, as this might however be changing, 
as several studies have shown that urbanisation and the nutrition transition in South 
Africa is accompanied by an increase in the CVD risk factors in those of African 
descent. According to Venter (2008) urbanisation lead to a lifestyle change and with it 
a reduction in physical activity. This combined change is a known risk factor for 
increasing hypertension, may explain the 40.2 % prevalence of hypertension found in 
West-African urban subjects (35 years and older). 
 
Several studies and reviewed data on Sub Saharan black Africans scientifically suggest 
that black Africans pose higher vascular reactivity, “but whether this contributes to 
smooth muscle cell changes, and the underlying mechanism thereof, is largely 
unknown” (Venter, 2008). More data is however needed to determine whether this 
increase in CVD risk is related to urbanisation per se, or whether socio-economic 
position influences the nutrition transition and related increase in CVD risk. 
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1.3  BACKGROUND 
It has been scientifically assumed from the start that Cardiovascular Diseases do not 
have a single cause. Rather it is a result of multiple causes which worked slowly on the 
individual to produce the disease. Reliable data on disease progression of 
cardiovascular disease and its risk factors has been recorded differently among 
individuals and countries. In the Eastern Cape region: South Africa there has not been 
sufficient data reported on disease progression and currently rely on studies done in 
other countries and provinces, such as the Heart of Soweto Study, a risk factor profile 
for chronic lifestyle disease in three rural Free State towns to name a few. 
1.4 PROBLEM STATEMENT 
When the African National Congress (ANC) led government democratically assumed 
power in South Africa in 1994 using two pre- election document (The Reconstruction 
and Development Programme :RDP and a National Department of Health: National 
Health Plan for South Africa) as means to guide the imminent reform and declaring free 
health services for all. The National Health Plan for South Africa clearly elaborated in 
detail the post-apartheid health strategy and viewed health from a development 
perspective (National Health Policy, 1994). The plan aimed at redressing and reforming 
the country’s health care system which was suffocated by major past distortions, 
inequalities and inefficiency in health care delivery that was influenced by racial 
segregation (Van Rensburg, 2011).  
South Africa is a country of great diversity, extending from highly industrialised cities 
where people follow urban westernised lifestyle to remote rural regions with traditional 
lifestyles. Pre 1994 health data show that infectious and parasitic diseases were 
responsible for 14% of deaths amongst Black people, 2% of deaths among White 
people.  Cardiovascular disease accounted for 12% of deaths among Blacks (4 million), 
and 40% of deaths among Whites, that is, 2 million (National Health Policy, 1994). 
Back then, mortality and morbidity was strongly related to poor environmental and 
socio-economic circumstances as well as to lifestyle. Chronic diseases were emerging 
as an increasing problem in all population groups especially in the rural areas (National 
Health Policy, 1994).  Twenty years later, the situation has exacerbated with an 
increase in urbanisation, cardiovascular disease related risk factors are becoming more 
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and more prevalent among blacks namely hypertension, diabetes and obesity. This 
highlights the magnitude of the problem our country is facing. Within the Eastern Cape 
Province: South Africa, prevalence of CVD and determinants differ, in Joe Gqabi District 
during 2011/2012 financial year, hypertensive heart disease accounted for 2.9% Years 
of Life Lost (YLL) and 1.9% on ischaemic heart disease.  
Joe Gqabi District in 2013, there has been a significant increase in the working-age 
population which was 34.2% of the total population which are in the working age 
group (that is, 20-49 years) and 14.59% between 50-79 years. This demographic shift 
has both positive and negative district policy implications which are influenced by 
socioeconomic and behavioural patterns. During 2012/2013 financial year, the district 
prevalence of hypertension was at 29.2% and 2013/2014 first quarter prevalence on 
25.8% with Maletswai Sub District (semi urban) at 35.2% as the highest among the 
three sub district. Figure 1.1 cited from Massyn, et al. (2014) elaborates the top ten 
leading causes of mortality in Joe Gqabi District, and amongst the top five, 
cerebrovascular disease accounts for 3.4% of mortalities. Followed by Hypertensive 
heart disease accounting for 2.9% of year’s life lost and lastly, Ischaemic heart disease 
which accounts for 1.9% of years of life lost.  
The continued occurrence of CVD especially in this District (Joe Gqabi) which is 
characterized by heavy resource constraints calls cost effective interventions in the 
management of cardiovascular disease. This provides compelling reasons for a detailed 
demonstration of risks factors which motivates for an important step towards 
investigating why the apparent failure of the interventional programs and this proximal 
and district determinants of CVD. 
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Figure 1.1: Leading of causes of death in Joe Gqabi District, Eastern Cape 
 
Source: District Health Barometer 2012/2013 (Massyn, et al., 2014) 
1.5 RATIONALE  OF THE STUDY 
The lack of valid information on the etiology of CVD in Joe Gqabi District: Eastern Cape 
justified the initiation of the present study. 
1.6 SIGNIFICANCE OF THE STUDY 
It is then, that the researcher felt an extreme urgency to assess the risk factors of 
coronary heart disease among rural adults in the Joe Gqabi District: Eastern Cape 
Province. This has been fuelled by the affirmation of the Ministry of Health on the 
unequal development which includes poverty and health illiteracy which is strongly 
associated with increased mortality and morbidity. Furthermore, the researcher also 
feels that the baseline analysis and findings of the study will assist in the latest focus of 
developing a tailored detection and treatment strategies for those individuals 
unfortunate enough to develop clinically detectable forms of CVD and in development 
of integrated care interventions for cardiovascular disease in the district in order to 
shorten what is shaping up to be a devastating epidemic in vulnerable communities 
subject to the profound effects of epidemiological transition. 
1.7 RESEARCH QUESTIONS OF THE STUDY 
The research questions were raised as follows: 
1. what are the risk factors of CVD (Coronary Heart Disease) in Joe Gqabi District, 
Eastern Cape: South Africa? 
         
2. what are the most important independent risk factors among non modifiable,           
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environmental risk factors, socio demographic risk factors, traditional risk factors, 
physiological risk factors, lifestyle/behavioural factor and psychological factors.   
1.8 AIM 
The aim of this study was to assess the risk factors of coronary heart diseases (CHD) 
among rural adults in Joe Gqabi: Eastern Cape Province with a purpose of accelerating 
and strengthening the planned health promotion (primary intervention) activities. 
1.9 OBJECTIVES OF THE STUDY 
The objectives of the study were specifically designed to achieve the aim of the study 
as follows: 
1. To determine the demographic profile of diagnosed CHD cases and undiagnosed  
controls 
2. To determine the anthropometric risk factors of diagnosed CHD cases and 
undiagnosed  controls 
3. To assess the behavioral determinants of cardiovascular diseases (diet, smoking 
habits, alcohol use and physical activity) among diagnosed CHD cases and 
undiagnosed controls 
4.  To describe the environmental risk factors and psychological risk factors of 
diagnosed CHD cases and undiagnosed controls 
 
1.10 THEORETICAL FRAMEWORK WITH CONCEPTUAL MODEL OF THE STUDY 
AND HYPOTHESIS  
According to the evidence in the literature and experience of the researcher, among 
black South Africans, the theoretical framework develops a process, knowledgeable 
within the conceptual model of the study using a diagram (Figure 1.2). 
The process considers the dependent variable such as Coronary Heart Disease (CHD)/ 
Ischaemic Heart Disease or Coronary Artery Disease with other CVD (Severe Stroke, 
Cardiac Failure, and Peripheral Artery Disease). At the right end bottom of the diagram 
explained by different variables at the left of the diagram  
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The independent variables include non modifiable risk factors, modifiable risk factors 
(physiological or biological risk factors of CVD: control of hypertension and Type 2 
Diabetes Mellitus, lifestyle or behavioural factors, psychological factors) and contextual 
or environmental risk factors. 
These factors were clustered as moderators of the relationships between major risk 
actors and the severity of cardiovascular disease (CHD, Peripheral Artery Disease, and 
Stroke). The conceptual framework of this study is presented in Figure 1.2. 
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Figure1.2 Conceptual Framework of CHD in the study 
Non Modifiable Risk Factors 
 Age 
 Gender 
 Family History of 
CVD/Heredity 
Modifiable Risk Factors 
Physiological/Biological Factors 
 Elevated Blood Pressure 
 Abnormal serum 
cholesterol 
 Diabetes Mellitus 
 Obesity 
 Menopause 
Behavioural/Lifestyle Factors 
 Smoking 
 Physical Inactivity 
 Diet 
 Excessive alcohol 
consumption 
 
Psychological Factors 
 Stress 
 Depression 
 Environmental Risk 
Factors 
 Socio economic status 
(level of income) 
CVD  
Coronary Heart Disease 
with and without 
CVA/Stroke, Peripheral 
Artery Disease, Cardiac 
Failure 
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DEFINITION OF TERMS 
Cardiovascular disease has been commonly defined as diseases which encompass 
conditions or disorders of the heart and refer to “any disease of the heart and blood 
vessels (Steyn, 2007). The most common ones are disease of the heart muscle, 
strokes, heart attacks, heart failure and heart disease” (Steyn, 2007).  
Coronary Heart Disease (CHD) is a disease resulting from narrowing of the arteries 
carrying blood to the heart muscles. CHD includes sudden death, heart attack, unstable 
angina, chronic angina and often heart failure (Capewell, et al., 2008). 
 
Peripheral Arterial Disease is a deficit caused by ischaemia due to impaired blood 
flow to a limb. This commonly affects one or both legs causing muscle pains, leg 
ulcers, gangrene of the lower limb (Capewell, et al., 2008).  
 
Congenital Heart Disease is a heart condition resulting from any abnormality in 
heart structure or function that is present at birth.  Most congenital heart conditions 
occur because the heart or its valves or vessels are not properly formed. Additional 
defects such as holes between the chambers of the heart may be present (Capewell, et 
al., 2008). 
 
Rheumatic Heart Disease is a condition in which permanent damage to heart valves 
between the chambers of the heart occurs. The heart valves are damaged by a disease 
process called rheumatic fever which begins with a throat infection caused by a 
streptococcus bacterium (Steyn, 2007). 
 
Ischaemic Heart Disease is characterized by reduced blood supply to the heart 
muscle, that is, myocardium (Capewell, et al., 2008) 
 
Valvular Disease a disease of the valves within the heart that are needed to regulate 
blood flow, valvular disease means that the valves either do not open enough to allow 
blood  to flow freely or they do not close effectively and blood cab flow backwards. 
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Inflammatory Heart Disease involves inflammation of the heart muscle and or the 
tissue surrounding it (Steyn, 2007) 
 
Pulmonary Embolism is a sudden blockage of the main artery of the lung or one of 
its branches by blood clot, the blockage usually is caused by a blood clot that travels to 
the lung from a vein in the leg (Capewell, et al., 2008). 
 
Hypertension is often referred to as high blood pressure, is a condition in which the 
arteries have persistently elevated blood vessels. Every time the human heart beats, it 
pumps blood to the whole body through arteries (Steyn, 2007). 
 
Morbidity refers to people who have a disease or condition but have not yet died of 
this (Steyn, 2007). 
 
Prevalence refers to the percentage of people in the population who have a condition 
at any point in time (Steyn, 2007). 
 
Chronic Non Communicable Diseases are illnesses that are preventable, prolonged 
unlikely to resolve spontaneously and impossible to cure completely (National 
Department of Health, 2009). 
Heart Failure is a condition that occurs when the heart is no longer able to pump out 
enough oxygen-rich blood and is often a long term chronic condition (Capewell, et al., 
2008). 
 
Risk Factor is defined as “a measurable characteristic that is causally associated with 
increased disease frequency and that is a significant independent predictor of an 
increased risk of presenting with the disease.” (O’Donnell, et al., 2008) 
Determinants of Health are defined as many factors combined together to affect the 
health of individuals and communities, whether people are healthy or not, and are 
determined by their circumstances and environment (WHO, 2012).  
 
Determinants are defined as ecological factors that provide the background in which 
a disease develops and not to be directly linked to the disease causally (Mbewu, et al., 
2006). 
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Depression is defined generally as a mood state characterized by a sense of 
inadequacy, a decrease in activity or reactivity, pessimism, sadness and related 
symptoms (Reber, et al., 2009) 
Multivariate Analysis a genetic term used to cover any of several statistical 
techniques for examining multiple variables at the same time including factor analysis, 
multiple linear regression, multivariate analysis of variance and multivariate of 
covariance (Reber, et al., 2009).  
Univariate consisting of but one variable, an experiment using only one variable may 
be called a univariate study (Reber, et al., 2009).  
Variable that which changes, that which is subject to increases and/or decreases over 
time (Reber, et al., 2009).  
Independent Variable is any variable the values of which are in principle, 
independent of the changes in the values of other variables, therefore, if the variables 
represent an outcome of the study (Reber, et al., 2009).  
Dependent Variable is defined as “any variable the values of which are, in principle, 
the result of changes in the values of one or more independent variable or if they are 
presumed to influence the value of the dependent variable” (Reber, et al., 2009).  
Diabetes Mellitus is defined as a cluster of metabolic disorders characterised by 
hyperglycaemia high enough to significantly increase the incidence of a specific and 
unique type of microangiopathy (Alemu, 2015) 
Type 2 Diabetes Mellitus is a metabolic disorder that is defined by high blood 
glucose levels due to insulin resistance and a relative insulin deficiency (American 
Diabetes Association, 2014). 
Rural is the proportion of population living in a non-urban environment.  Non-urban, 
or rural areas include commercial farms, small settlements, rural villages, former 
homelands and other areas which are further away from towns and cities created by 
the apartheid removals, which depend for their survival on migratory labour and 
remittances. (Statistics South Africa, 2001).  
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 CHAPTER 2:  LITERATURE REVIEW 
2.1 INTRODUCTION 
In the midst of health transition, and the country’s success on health care, the decline 
in infectious diseases particularly HIV/AIDS, gradual reduction in child deaths and 
maternal deaths, implementation of the Reengineering Primary Health Care, National 
Health Insurance, implementation of the Millennium Development Goals and National 
Development Plan vision 2030.  The reality is that Africa and South Africa is challenged 
by the rise in chronic diseases dubbed as “Tsunami of NCDs” by Volmink (2011).  
Mbewu (2009) highlights that, historically CVD was seen a disease of affluence 
afflicting populations in the industrialized world, however this has in fact changed. Poor 
socio-economic conditions in childhood determine CVD in the middle age. David Barker 
as cited by Mbewu (2009) introduced the “fetal origins” at which it was quoted “The 
fetal origins hypothesis states that fetal under nutrition in middle to late gestation, 
which leads to disproportionate fetal growth, programmes later coronary heart disease 
and hypertension.” This meant that, individuals who were born small and became 
heavier childhood are highest risk of cardiovascular disease as they go through “catch-
up growth.” 
2.2 EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN AFRICA 
Epidemiology involves the study of disease frequency and its determinants within the 
population, cardiovascular epidemiology began in the 1980s as a result of changes in 
the causes of death (O’Donnell, et al., 2008). In the 1950s several epidemiological 
studies were set in motion with the aim of clarifying the cause of cardiovascular disease 
and a few years later the Framingham Heart study started, at the time researchers had 
identified that high levels of cholesterol and high blood pressure were important factors 
in the development of cardiovascular diseases (O’Donnell, et al., 2008) 
Africa is a continent of great diversity where it consists of extremely poor and remote 
rural regions with traditional existence and while there are highly industrialized cities 
which are populated with people following an urban westernized population. Mbewu 
(2009) publicised that in Africa, epidemiological data is scanty and off poor quality. 
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National vital registrations are only available in five percent (5%) of Africa’s fifty three 
(53) countries. Whilst verbal autopsy has shown to be economically and useful way of 
improving the quality of cause of death information. Sentinel surveillance has also 
proven useful in the monitoring changes in CVD prevalence with disease surveys 
periodically conducted. Demographic health surveys are conducted in several African 
countries which include South Africa.   
Gradually the prevalence of CVD in South Africa continued to rise through the 1980s 
becoming the third most common cause of death in a prospective autopsy study where 
90 of the 167 deaths in one year at Tshepong Hospital in the North West province of 
South Africa (Mbewu, 2009). 15 Of these CVD deaths, 32% were cerebrovascular 
events, (intracerebral haemorrhage in 50%, cerebral infarction in 29%); pulmonary 
hypertension in 31%; dilated cardiomyopathy 17%, chronic rheumatic valvular disease 
17%, and hypertensive heart disease 14%. Only 3% of the examined vessels had signs 
of severe atherosclerosis (Mbewu, 2009).  
2.3 TYPES OF CARDIOVASCULAR DISEASE 
 Heart related cardiovascular disease include the following: coronary heart disease 
(CHD), cardiomyopathy, congenital heart failure, valvular diseases, congestive heart 
failure, inflammatory heart disease, rheumatic heart disease, Heart failure, Ischaemic 
heart disease, angina, and arrhythmia.  
2.3.1  Coronary Heart Disease 
Coronary heart disease (CHD), also known as coronary artery disease, is a disorder of 
the coronary arteries around the heart (which supply oxygen and nutrients to the heart 
muscle) in which the regional blood supply is insufficient to deliver the oxygen needed 
by the heart muscle. CHD is almost always due to atheroma (fatty deposit in the blood 
vessel); with estimates that over 20% of CHD worldwide being due to a lack of physical 
activity or exercise (Libby, 2005).  
In Libby (2005) it is outlined that, amongst most developed countriesm CHD is the 
leading cause of death, and accounts for 17% of all deaths and 49% of deaths from 
cardiovascular disease in Australia. In South Africa coronary heart disease is the major 
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cause of death among white people and South Africans of Indian descent, with 
incidence rates of 165.3 and 101.2 per 100 000 people respectively, but only 55.1 per 
100 000 among people of mixed descent and 5.3 per 100 000 among black African 
people (Mbewu, 2009).  
The increase in coronary heart disease (CHD) in sub-Saharan Africa is presumably 
owed to the epidemiological transition impelling the developing communities to 
westernization which has attributed to the gradual increase of prevalence on classical 
risk factors for CHD among African populations which are: smoking, a diet high in 
saturated fat, high sodium intake, hypertension, obesity, diabetes mellitus, and lack of 
physical exercise (Akintunde, 2010). In addition, life expectancy in sub- Saharan Africa 
has risen so that more people are exposed to these risk factors for long enough periods 
to cause CHD.  
2.3.2  Rheumatic Heart Disease 
Rheumatic heart disease (RHD) is referred as the most common acquired heart disease 
in children in many countries of the world, especially in developing countries. The 
global burden of disease caused by rheumatic fever currently falls disproportionately on 
children living in the developing world, especially where poverty is widespread. RHD is 
a chronic heart condition caused by rheumatic fever that can be prevented and 
controlled (Mendis, et al., 2011). Rheumatic fever is caused by a preceding group (. A 
streptococcal (strep) infection. Treating strep throat with antibiotics can prevent 
rheumatic fever. Moreover, regular antibiotics (usually monthly injections) can prevent 
patients with rheumatic fever from contracting further strep infections and causing 
progression of valve damage (Mendis, et al., 2011). 
In the 1980s, most of sub-Saharan Africa was in stage one of the epidemiological 
transition (Age of pestilence and famine) which is characterised by uncontrolled 
infection and deficiency conditions as risk factors (Mbewu, 2009). During the period, 
Rheumatic heart disease (RHD) accounted for 10% to 35% of hospital cardiac patients 
in sub-Saharan Africa and up to 20% of cardiac deaths. 
 In Soweto, Gauteng, the incidence of RHD among primary school children was 6.9 per 
1 000; and in Ibadan, Nigeria, the incidence was 3 per 1 000 among children. RDH as 
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explained by Mbewu, is a disease of poverty, related to overcrowding, poor housing, 
and under nutrition and requires a multi-sectoral response for prevention and cure. It is 
caused by group beta-haemolytic streptococci. The principal methods of control are 
primary and secondary prevention of streptococcal infection.  
2.3.3   Dilated Cardiomyopathy 
Dilated Cardiomyopathy develops when the ventricles enlarge and weaken. The 
condition usually starts in the left ventricle and over time can affect the right ventricle 
(Elliot, 2000).  Elliot (2000) also outlined that, the weakened chambers of the heart 
don’t pump effectively, causing the heart muscle to work harder. Over time, the heart 
loses the ability to pump blood effectively. Dilated cardiomyopathy can lead to heart 
failure, heart valve disease, irregular heart rate, and blood clots in the heart (Elliot, 
2000). 
In the Sub- Saharan Africa, a Dilated Cardiomyopathy (DCM) is surprisingly common 
and accounting for up to 20% of cardiac cases in some regions (Mbewu, 2009. 
Occasionally the disease is familiar with specific candidate genes recently identified. 
There may be a whole spectrum of causes of DCM, including genetic etiology, toxins, 
and vitamin or micronutrient deficiency, such as selenium deficiency. Dilated 
cardiomyopathy is often seen as a late complication of HIV infection (Mbewu, 2009). 
2.3.4   Congenital Heart Disease 
Congenital heart disease, in a definition proposed by Mitchell et al., is defined as “a 
gross structural abnormality of the heart or intrathoracic great vessels that is actually 
or potentially of functional significance.” (Hoffman, 2002). This definition excludes 
functionless abnormalities of the great veins, such as persistent left superior cava (even 
though this might be important during surgery), or of the branches of the aortic arch 
such as a combined brachiocephalic-left carotid arterial trunk. Even though the 
abnormal genes that cause these disorders are present at birth, the cardiomyopathy is 
rarely detected at this time but usually presents later in childhood or adolescence. 
Another genetically determined lesion, Marfan syndrome, is often included as CHD 
because the phenotype may be present at birth, although because the cardiac and 
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aortic lesions may not appear for many years not all studies include this syndrome 
(Hoffman, 2002).  
2.3.5   Cerebrovascular 
Cerebrovascular disease refers to a group of conditions that affect the circulation of 
blood to the brain, causing limited or no blood flow to affected areas of the 
brain. Cerebrovascular disease is one of the most common reasons for neurological 
emergencies and constitutes a serious public health problem (Ustrell-Roig, et al., 
2007).  
. Brain related cardiovascular diseases include the following: myocardial infraction 
cerebrovascular disease (stroke and transient ischemic attacks), Haemorrhagic stroke 
and Ischaemic stroke 
Data extracted from the World Health Organisation indicates that, cerebrovascular 
disease is the most common cause of death and the leading cause of disability (Ustrell-
Roig, et al., 2007).  
2.3.6   Stroke 
A serious medical condition where one part of the brain is damaged by a lack of blood 
supply or bleeding into the brain from a burst blood vessel. A stroke happens when the 
blood supply to part of the brain is blocked or interrupted, for example, by a blood clot 
(where the blood thickens and solidifies). This is the most common cause of stroke and 
is known as an ischaemic stroke (Behrouz, et al., 2012). 
 
The lack of blood causes part of the brain to die, a process known as cerebral 
infarction. About 10% of strokes are caused by bleeding from the arteries in the brain, 
which directly damages the brain's tissues and can also cause loss of blood supply. This 
is known as haemorrhagic stroke or cerebral haemorrhage (Behrouz, et al., 2012). 
Stroke is probably the commonest form of CVD in sub-Saharan Africa today, having 
progressed in the latter half of the twentieth century as a result of increased life 
expectancy and changes in environmental determinants and risk factors. The majority 
of strokes occur in young and middle-aged people and are related to hypertension. 
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South Africa in 2006, stroke has accounted for 5% of deaths. The number of reported 
stroke deaths has more than doubled since 1995 (reaching 34 926 deaths in 2006), the 
actual proportion of total deaths has fallen from 6.6% in 1995 to 4.6% in 2006 of total 
deaths due to the tripling of number of deaths largely due to HIV and AIDS and 
tuberculosis (Mbewu, 2009).   
2.4 DIAGNOSING CARDIAC DISEASE  
During the Framingham study in the early 1950s, persons at high risk of cardiovascular 
disease were effectively identified from a measurement of their serum cholesterol and 
blood pressure, smoking history, an electrocardiogram and a determination of glucose 
intolerance. During the study, one of the general functions for identifying persons at 
high risk of cardiovascular disease was to effectively identify each of the specific 
diseases (that is, coronary heart disease, atherothrombotic brain infarction, 
hypertensive heart disease) for the at risk person.  
2.4.1   History and examination 
Today, many cardiac disorders can be identified by a clinical examination and a 
patient’s history where patients will complain of recurrent chest pains, but in the 
majority, if not all cases, an echocardiogram is required to confirm clinical suspicions 
(Elliot, et al., 2014).  Heart attack (myocardial infarction) is usually diagnosed from the 
reported medical history of sudden severe pain in the central chest, neck or arm, which 
can then be confirmed by an electrocardiogram and blood tests to measure cardiac 
enzymes.  
2.4.2   Special investigations 
Investigations such as an electrocardiogram (ECG), a machine that measures and 
records the heart rate and rhythm or an echocardiogram also a cardiac machine which 
technically is more difficult are used as investigative tools. The transthoracic 
echocardiogram is the most important screening and diagnostic tool in identifying 
structural lesions and assessing cardiac function (Elliot, et al., 2014). In the Sub 
Saharan region, confirmation of the diagnosis of CVD relies essentially on 
echocardiography which is performed in few referral centres in urban areas due to low 
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availability of human resources for cardiovascular care (Mocumbi, 2012). Interventional 
cardiology and cardiac surgery are not readily available in most countries and in some 
services rely essentially on collaborative partnerships that bring teams from overseas to 
perform cardiac catheterization and surgery, for example, in Mozambique, there is only 
one catheterization laboratory and two centres performing open heart surgery, the 
country has 13 cardiologists and 3 cardiac surgeons Mocumbi (2012).   
In managing CVD, the WHO issued out National Essential Medicine list at which 
countries can use to manage cardiovascular diseases (Mocumbi, 2012). But there has 
been less compliance for reasons that seem to be related to political will, insufficiency 
of human resources or funding and conflict of interest (Mocumbi, 2012).  
2.5 GLOBAL BURDEN OF CARDIOVASCULAR DISEASES 
In 1998 worldwide, the World Health Organization’s CVD estimations were on 28.5%, 
as evolution of epidemiological transition occurred, chronic non communicable diseases 
drastically became the leading causes of mortality and morbidity. In 2002 World Health 
Organisation declared cardiovascular diseases as among the leading causes of mortality 
and responsible for one third global deaths (WHO, 2002). 85% of these mortalities 
occurred in low to middle income countries and the mortality burden was largely the 
result of an increase on behavioural risk factors such as smoking, alcohol usage, and 
decreases in physical activity (Gaziano, 2007). 
2.6 NATIONAL BURDEN OF NON COMMUNICABLE DISEASES AND 
CARDIOVASCULAR DISEASE 
Current evidence indicates that chronic non communicable diseases account for 35% of 
mortalities within low- middle income countries and this is expected to rise in future by 
2030 (Mondo, et al., 2013). Chronic Non Communicable Diseases negatively affect the 
country’s economic, financial and health costs as countries have to invest more on 
prevention measures, which include health promotion.  
 
Future predictions by the World Health Organization (2002) illustrates that, the burden 
of diseases resulting from Chronic non communicable diseases will sharply increase and 
possibly double the number of deaths to communicable disease, and if nothing is done 
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to address this, the risk of chronic illness the country’s active economic production 
would be lost to heart diseases, stroke and diabetes.  Further estimates by WHO 
(2002) on Chronic NCD places South Africa as two to three times higher than that in 
developed countries. 
The South African Ministry of Health identified chronic non communicable diseases as 
major contributors to the burden of diseases as there has been a recorded trend 
increase in the chronic diseases (National Department of Health, 2009). In Joe Gqabi 
District: East Cape Province, chronic non-communicable diseases are among the top 
(10) diseases contributing to mortality.  Both these statements mirror the alarming 
state of health our country and rural districts are facing.  
In South Africa, stroke has been documented as highest among females and ischaemic 
heart disease is highest in males, while hypertensive heart diseases feature top death 
for females (Bradshaw, et al., 2003).  In 1995, strokes accounted for 6.3% and 
ischaemic heart disease for 5.6% of deaths among males aged 45-49 and in women 
stroke accounted for10% and IHD accounted for 3.8%. 
Even though in Joe Gqabi District: East Cape Province the hypertension detection rate 
has varied between 0.3% to 0.4% over the past 5 years, and has been in line with the 
Provincial and National averages for the same period, cerebrovascular diseases has 
been recorded to be at 3.4% of Years of Life Lost during 2011/2012 financial year and 
leading cause of death on chronic non communicable diseases.  
The burden of cardiovascular related disease are escalating among rural communities 
and the poor have been affected mostly especially those who have migrated to urban 
settings (National health policy, 1994). 25% of the South African health care spending 
will be devoted to cardiovascular diseases as the proportion of South Africans living in 
rural areas has fallen by about 10% since 1994, with concurred escalation to 60% of 
the population living in urban areas (National Development Plan 2030).  
In 2012/2013 South Africa’s average hypertension detection rate was 0.25%. Over a 
third of the districts in Eastern Cape had hypertension detection rates above the 
national average, with John Taolo Gaetswe District (Northern Cape Province) and Gert 
Sibande District (Mpumalanga Province) ranked first and second respectively and 
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Capricorn (Limpopo Province) ranked last, whilst Joe Gqabi’s hypertension detection 
rate 29.2% (Massyn, et al., 2012).  
Upon analysing the major causes of Years Life Lost, in the top ten (10) leading causes 
of the country’s Years Life Lost cerebrovascular diseases, hypertensive heart disease, 
and ischaemic heart disease are ranked 5th, 8th and 10th respectively. In 2008 and 2009 
the burden on CVD in Eastern Cape has been above 30% putting pressure for the 
province to develop and implement integrated interventional programs.  
The World Health Organization and World Bank data predicted that over the next 30 
years not only will there be an almost doubled on CVD related deaths in South Africa, 
but an increasing proportion (41%) of these will be among the working-age group 
(ages 35-64) as compared to other age groups (Chopra et al., 2007). Thus impacting 
negatively on economic costs both directly (health care) and indirectly (such as loss of 
workers and productivity). 
2.7 COST OF CARDIOVASCULAR DISEASE 
There is no legal standard or regulation for what is cost effective, however the World 
Health Organization (WHO), Commission on Macroeconomics and Health recommended 
choosing interventions that were less than three times a country’s GNI per capita 
(Gaziano, 2007). In 2003, cardiovascular disease cost the European Union €169 billion 
and $475.3 billion in direct and indirect annual costs in the USA in 2009. Similar 
information is minimal in South Africa as recent data shows that total costs of heart 
disease and stroke accounted for 2 to 3% of the GDP of the country in 1991 (i.e. 
between R4 135 billion and R5 035 billion). Direct costs comprised 42% of the total, of 
which 75% was carried by the private sector. Assuming a 4% rate of inflation, and a 
higher prevalence of CVD, the overall costs for CVD in 2010 would be more than 
double that 20 years ago (Maridza, et al., 2011). 
2.8 KNOWN RISK FACTORS AND DETERMINANTS  ASSOCIATED WITH 
CVD IN SOUTH AFRICA 
South Africa has a well-documented and complex burden of diseases which includes 
the emergence of chronic non-communicable diseases such as cardiovascular disease, 
diabetes, cancer and chronic respiratory diseases (Kahn, 2011). These diet related 
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disease ailments which account for a large proportion of South Africa’s disease burden 
are expected to rise further especially among poor African women.  These chronic 
diseases have multiple preventable risk factors operating at different levels, from 
biological to structural factors (Puoane, et al., 2013). These factors can be classified as 
both modifiable (factors that can be altered, for example, living conditions, socio 
cultural factors and community influences) and non-modifiable (factors beyond control 
for example, age, sex and hereditary factors) (Puoane, et al., 2013). 
 
2.8.1 DETERMINANTS OF CVD  
Many factors combine together to affect the health of individuals and communities, 
whether people are healthy or not it is determined by their circumstances and 
environment. To a large extent, factors such as where we live, the state of our 
environment, genetics, our income and education level and our relationships with 
friends and family all have considerable impacts on health (WHO, 2011).  
Determinants are defined as ecological factors that provide the background in which a 
disease develops and not to be directly linked to the disease causally (Mbewu, et al., 
2006). More people exposed to determinants do not inevitably develop the disease. 
Genetic determinants provide the foundation on which behavioural, sociocultural, 
economic and educational determinants build (Mbewu, et al., 2006).  
 
2.8.1.1   Urbanization 
One major determinant in South Africa as shared by BeLue, et al. (2009) is 
urbanization. Globally, Sub Saharan Africa is the least urbanised region which is rapidly 
urbanising. Compared in 2001, 50% of the population was already urbanised and at 
the time projections were expected to increase to 62% by 2025 (Van Rensburg, et al., 
2011). The South African population is currently more mobile compared to few decades 
ago. The shift of population from rural to urban brings with its substantial implications 
for nutrition, access to food and preventative health care. An environment that 
increases health risk exposure which also includes under nutrition and malnutrition. 
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Available literature suggests that the exploding growth in cities often results in 
deterioration in the health and well-being of people due to poor quality of urban 
housing, sanitation issues and limited access to efficient health care system. 
Furthermore, it has been outlined that, urbanization plays a significant role in 
increasing the burden of CVD. 
2.8.1.2   Socio cultural 
While understanding the burden of clinical CVD risk conditions is an important step 
towards addressing the epidemic of CVD in South Africa, it is also important to 
understand the contributing and competing socio cultural context and related lifestyle 
beliefs and behaviours associated with the burden of these clinical risk factors (BeLue, 
et al., 2009).  
The Framingham Heart study, InterHeart study and MONICA project and all other 
studies were initial steps towards exploring and surveying the causes of CVD in 
different populations across the world and the importance of known and emerging risk 
factors.  
Figure 2.1: The pathway model, illustrates the proximal societal level determinants plus 
individual level information on nutrition, lifestyle factors, biological markers as well as 
genetic variations. Jeemon, et al. (2009) the pathway model emphasizes the 
cumulative effect of life events and the reinforcing effect of differing psychological and 
socio-economic circumstances throughout life cycle. The duration of exposure to at risk 
living conditions has a dose effect on subsequent health and well-being. 
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Figure 2.1: The Pathway model: Causal diseases Pathways for cardiovascular disease 
(Yusuf et al., 2002) 
2.8.2 RISK FACTORS OF CVD 
The Framingham study and other epidemiological studies helped in the identification 
risk factors associated with cardiovascular disease which are now considered as 
classical risk factors.  A risk factor is defined as “a measurable characteristic that is 
causally associated with increased disease frequency and that is a significant 
independent predictor of an increased risk of presenting with the disease.” (O’Donnell, 
et al., 2008). 
Risk factors arise from determinants and are directly linked to a disease in a casual 
manner, although not everyone with the risk develops the disease (Mbewu, et al., 
2006).  
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2.8.2.1 MODIFIABLE RISK FACTORS  
2.8.2.1.1 PHYSIOLOGICAL RISK FACTORS 
Modifiable risks factors include abnormal blood cholesterol (elevated total cholesterol, 
triglycerides, LDL-C, and low HDL-C levels), hypertension (especially systolic blood 
pressure elevations), cigarette smoking, physical inactivity, cocaine, glucose intolerance 
and diabetes mellitus (Crawford et al., 2010).  
2.8.2.1.1 Triglycerides 
Abnormal blood lipid levels, which is high total cholesterol, high levels of triglycerides, 
high levels of low-density lipoprotein or low levels of high-density lipoprotein (HDL) 
cholesterol all increase the risk of heart disease and stroke. Pisa, et al. (2011) warns 
that a diet with excess saturated and trans-fats leads to dyslipidaemia and especially 
hypercholesterolemia a risk factor for CVD. Therefore changing to a healthy diet, 
exercise and medication can modify your blood lipid profile. 
2.8.2.1.2 Diabetes Mellitus 
Diabetes mellitus(DM) has been defined as a group of metabolic diseases characterized 
by hyperglycemia resulting from defects in insulin secretion, insulin action, or both 
(American Diabetes Associations, 2014) The chronic hyperglycemia of diabetes is 
associated with long-term damage, dysfunction, and failure of various organs, 
especially the eyes, kidneys, nerves, heart, and blood vessels (American Diabetes 
Association, 2014). 
Before the 1990s, diabetes was considered a rare medical condition in Africa. 
Epidemiological studies carried out in that decade, however provided evidence of a 
trend toward increased incidence and prevalence of type 2 diabetes in African 
populations (Mbanya, et al., 2006). The global diagnosis of Diabetes Mellitus in the year 
2000 was at an estimated to be 171 million (2.8% of the world’s population), a figure 
projected to increase in 2030 to 366 million (6.5%), 298 million of whom will be living 
in developing countries (Wild, et al., 2004).  
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In Africa, the estimated prevalence is 1% in rural areas and up to 5% to 7% in urban 
sub-Saharan Africa and between 8% and 13% in more developed areas such as South 
Africa and in populations of Indian origin (Sobngwi, et al., 2001). By 2025, the 
prevalence of DM in sub-Saharan Africa is expected to be more than double the current 
figures (Wild, et al., 2004). Table 2.1 and Table 2.2 illustrate the criteria for diagnosing 
Diabetes Mellitus and classification, according to the American Diabetes Association 
(2014).  
During the African InterHeart study which looked at the contribution of conventional 
risk factors among subjects with coronary heart disease, it was established that 90% of 
the study participants had the convectional risk factors of smoking, diabetes mellitus, 
hypertension and abdominal obesity (Akintunde, 2010). Moreover, Coronary Heart 
Disease is a major cause of death among individuals with abnormal glucose tolerance. 
It has also been suggested impaired glucose tolerance develops slowly among 
hypertensive subjects (Akintunde, 2010).  
Table 2.1 Criteria for the diagnosis of Diabetes Mellitus (American Diabetes Association, 
2014)  
 HbA1C ≥6.5%. The test should be performed in a laboratory using a method 
that is NGSP certified and standardised to the DCCT assay. 
OR  
 Fasting plasma glucose ≥7.0mmol/L. Fasting is defined as no caloric intake for 
at least 8 hours. 
OR  
 2-hour plasma glucose ≥11.1mmol/L during an OGTT. The test should be 
performed as described by the WHO, using a glucose load containing the 
equivalent of 75g anhydrous glucose dissolved in water. 
OR  
 In a patient with classic symptoms of hyperglycaemia or hyperglycaemic crisis, 
a random plasma glucose concentration of ≥11.1mmol/L.  
 
NGSP: National Glycohemoglobin Standardization Program; DCCT: Diabetes Control and 
Complications Trial; OGTT: Oral glucose tolerance test; WHO: World Health 
Organisation 
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Table 2.2. Diabetes Classification (American Diabetes Association, 2014) 
Type 1 diabetes (due to β-cell destruction, usually leading to absolute insulin 
deficiency) 
 Type 2 diabetes (due to a progressive insulin secretory defect on the background of 
insulin resistance) 
  
 Other specific types of diabetes due to other causes, e.g., genetic defects in β-cell 
function, genetic defects in insulin action, diseases of the exocrine pancreas (such as 
cystic fibrosis), and drug- or chemical-induced (such as in the treatment of HIV/AIDS 
or after organ transplantation)  
  
 Gestational diabetes mellitus (GDM) (diabetes diagnosed during pregnancy that is not 
clearly overt diabetes) 
 
NGSP: National Glycohemoglobin Standardization Program; DCCT: Diabetes Control and 
Complications Trial; OGTT: Oral glucose tolerance test; WHO: World Health 
Organisation 
2.8.2.1.3 Hypertension 
Hypertension is the single biggest risk factor for cardiovascular disease or coronary 
heart disease in the African continent and has been declared by the African Union as 
one of the greatest health challenges to the continent other than HIV/AIDS, TB which 
plays a significant role in heart attacks (Onen, 2013). As explained by Venter (2008) 
the cause of hypertension is multifactorial and includes factors such as age, gender, 
urbanisation, obesity and malnutrition. Many of these independent and dependent risk 
factors coincide with the same factors causative of coronary heart disease (CHD).
 
Hypertension significantly and specifically contributes to heart disease, stroke and end-
organ failure (e.g. kidney failure). Currently one fourth of the United States of 
American (USA) population is affected and one third of the USA population still have 
uncontrolled Blood Pressure (Bell, et al., 2008). 
It can be prevented and successfully treated but only if you have it diagnosed and stick 
to your recommended management plan. But the problem is compounded by lack of 
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awareness, frequent under diagnosis, low levels of control and the severity of its 
complications (Onen, 2013).  
The mean Systolic Blood Pressure (SBP) ranges between and including 120 mmHg and 
139 mmHg or the mean Diastolic Blood Pressure (DBP) ranges between and including 
80 mmHg and 89 mmHg (Table 2.3) is introduced as pre-hypertension. 
Prehypertension is not a disease category. Rather, it is a designation chosen to identify 
individuals at high risk of developing hypertension and provide early intervention 
through adoption of healthy lifestyles that could reduce BP, decrease the rate of 
progression of BP to hypertensive levels with age, or even prevent hypertension 
entirely (National High Blood Pressure Education Program, 2004). Blood Pressure 
classification formulation is important in CVD primary management care 
Table 2.3. Changes in Blood Pressure Classification (Seventh Report of the Joint 
National Committee on Prevention, Detection, Evaluation and Treatment of High Blood 
Pressure (National High Blood Pressure Education Program, 2004) 
 
JNC6 Category 
Classification 
Systolic BP mmHg Diastolic BP mmHg JNC 7 category 
Optimal 120 mmHg 80 mmHg           Normal 
Normal 120-129  80-84  
 Prehypertension Borderline 130-139 85-89 
Hypertension ≥140 90         Hypertension 
Stage 1 140-159 90-99  
Stage 2 160-179 100-109  
Stage 3 ≥180 110  
BP= Blood Pressure 
Available data by Mbewu (2009) indicates that in mixed populations (coloureds) of 
South Africa, 50-60% of people over the age 65years have hypertension, and is also 
prevalent among 12% of adults with the Sub Saharan Africa who are often undetected 
and uncontrolled and in West Africa 30-40% of people aged 65 years or older in rural 
areas are affected by hypertension.  
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In 2013, SANHANES-1 (South African National Health and Nutrition Examination), 
clinical examination records indicated that, the mean systolic blood pressure for males 
was significantly higher than for females, but, the diastolic blood pressure did not differ 
significantly by gender. Mean systolic blood pressure and diastolic blood pressure 
increased progressively with increasing age from a mean of 118.1 mmHg to over 149.3 
mmHg in the over 65 years of age group and 66.4mmHg to 80.6mmHg respectively 
which plateaued between 54 and 65 years. This clinical examination differed from 
urban informal and rural informal, province to province (Shisana, et al., 2013). Upon 
conducting a racial comparison between white and coloured race, SANHANES-1, 2013, 
outlined that, white (130.8 mmHg) and coloured (132 mmHg) had the highest mean 
systolic blood pressure (Shisana, et al., 2013).  
The relationship between BP and risk of CVD events is continuous, consistent, and 
independent of other risk factors. The higher the BP, the greater the chance of heart 
attack, heart failure, stroke, and kidney diseases. The presence of each additional risk 
factor compounds the risk from hypertension (National High Blood Pressure Education 
Program, 2004) 
2.8.2.1.4 Obesity 
WHO (2006) defines Body Mass Index (BMI) as a simple index of weight-for-height that 
is commonly used to classify underweight, overweight and obesity in adults. It is 
defined as the weight in kilograms divided by the square of the height in metres 
(kg/m2). WHO (2006) BMI values are age-independent and the same for both sexes. 
BMI may not correspond to the same degree of fatness in different populations due to 
different body proportions. The health risks associated with increasing BMI are 
continuous and the interpretation of BMI grading in relation to risk may differ for 
different populations (WHO, 2006). Table 2.4 illustrates the classification of BMI in 
adults as per the World Health Organization.  
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Table 2.4.The International Classification of adult underweight, overweight and obesity 
according to BMI (Adapted from WHO, 1995, WHO, 2000 and WHO 2004.) 
 
 
Classification 
BMI (kg/m2) 
Principal cut-off points 
 
Additional cut-off points 
Under weight <18.50 <18.50 
Severe thinness <16.00 <16.00 
Moderate thinness 16.00-16.99 16.00-16.99 
Mild thinness 17.00-18.49 17.00-18.49 
Normal range 18.50-24.99 18.50-24.99 
Overweight ≥25.00 ≥25.00 
Pre obese 25.00-29.99 25.00-29.99 
Obese ≥30.00 ≥30.00 
Obese Class I 30.00-34.99 30.00-34.99 
Obese Class II 35.00-39.99 35.00-39.99 
Obese Class III ≥40.00 ≥40.00 
 
The health risks associated with increasing BMI are continuous and the interpretation 
of BMI grading in relation to risk may differ for different populations. Findings by 
Pretorius, et al., (2011) in the Heart of Soweto Study suggested that the most 
prevalent CVD risk factor by far was obesity were (43%), while up to 70% were 
overweight an observation that is consistent with other community-based surveys in 
the region, with far more obese women than men (23% versus 55%: OR 0.24 95% CI 
0.19 to 0.30: p <0.001).  
 
The fundamental importance of this finding should be emphasised, in a culture where 
low weight is either associated with the stigma of malnutrition or, worse, HIV/AIDS. It 
is difficult to educate individuals and the wider community about the dangers of excess 
weight. Cardiovascular disease risk factors are recorded to be high even in rural parts 
of South Africa. Some of these risk factors but not limited to render women at greater 
risk, for example, obesity is said to be higher in women than in men. And upon 
combining obesity and overweight is almost non-existent in boys than teenage girls 
(Kahn, 2011). 
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Indeed, the general lack of weigh scales both in the homes and healthcare facilities of 
Soweto are a major challenge in managing obesity even when an individual is 
committed to losing weight. 
 
2.8.3 BEHAVIOURAL RISK FACTORS 
2.8.3.1 Smoking 
As its components are absorbed into the bloodstream, tobacco smoking becomes an 
established risk factor for CVD through a variety of mechanisms. BeLue, et al., (2009) 
warns that tobacco use still remains as one of the most serious epidemiological risk 
factor in terms of prevalence of CAD and smoking prevalence is increasing among men 
and women in the Sub Saharan Africa. A review of tobacco use and smoking research 
showed that males are more likely to smoke than females and older males (30-49 
years) are more likely to use tobacco products than younger males. The prevalence of 
smoking also increased among women with age where 11% of the South African 
women have been reported to be smoking.  
 
The highest occurrence of smoking is among black men who are 53%, followed by 
coloured men and women (58% and 59% respectively) Indian men are at 48% while 
white males stand at 43% (Van Rensburg, 2011).  But once a person stops tobacco 
use, the risk of a coronary event among ex-smokers declines rapidly after quitting. 
After one year of smoking cessation, the risk of CHD is halved compared to those who 
continue to smoke (BeLue, et al., 2009). 
 
In an aid to prevent or reduce the rate of smoking in South Africa, the Tobacco 
Products Amendment Act of 1999 was passed. The aim was and it still to deal with the 
harmful effects of tobacco on the health of people. The act prohibited smoking in public 
places, sponsorship of sporting or any event and also included selling of tobacco 
products to minors (Tobacco Products Control Amendment Act, 1999). 
 
2.8.3.2  Excessive Alcohol Use 
In many parts of the world, including South Africa, using alcoholic beverages is a 
common feature of social gathering; this is a culture that has been there for centuries.  
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Among Africans, alcohol forms part of almost all traditional or cultural gatherings and 
this has been viewed as an acceptable practice (WHO, 2014). 
 
WHO (2014) defines alcohol as a psychoactive substance with dependence-producing 
properties. Consumption of alcohol and problems related to alcohol vary widely around 
the world, but the burden of disease and death remains significant in most countries.  
SANHANES-1, 2013 clinical examinations report outlined that, of those respondents 
who volunteered to undergo a clinical examination and were found to have a high 
blood pressure, more than two thirds were overweight or obese and less than a third 
consumed alcohol (Shisana, et al., 2013). The harmful use of alcohol ranks among the 
top five risk factors for disease, disability and death throughout the world. It is a causal 
factor in more than 200 diseases (WHO, 2014). 
 
In 2010, WHO approved a strategy to reduce the harmful use of Alcohol which was fast 
becoming a major public health concern, subsequently to that, in 2014 a global status 
report on alcohol and health was published. This report provided a global overview of 
alcohol consumption in relation to public health as well as information on the 
consumption of alcohol in populations, the health consequences and country policy 
responses. Despite all that, the consumption of excessive alcohol continued on to rise 
and posing adverse risk to health where chronic disease such as CVD, Liver cirrhosis 
may develop in those who drink large amounts over a number of years (WHO, 2014). 
 
In South Africa according to WHO (2014) the prevalence of heavy episodic drinking for 
males is 31.7% and 13.9% females among the ages of 15 years and above. In 
comparison with Swaziland (21.9% males, 7.4% Females), Zimbabwe (42% males and 
22.2% Females), Lesotho (16.9% males, 4.1% females) and Namibia (46.4% and 
23.6% females).  
 
As a political response to the raging public health hazard in South Africa laws, policies 
and interventions were put in place which includes excessing tax on beer, wine and 
spirits. Setting a national legal minimum age for off and on premise sales of alcoholic 
beverages, setting restrictions for on/off premise sales. Setting national maximum legal 
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blood alcohol concentration when driving a vehicle, legally binding regulations on 
alcohol advertising/product placement/ sponsorship, and Prevention of and Treatment 
for Substance Abuse Act (70 of 2008) was gazetted. Subsequently to that, The National 
Drug Master Plan (NDMP) 2013 – 2017 of South Africa was also formulated. Among its 
expected outcomes is to eliminate availability of dependence-forming 
substances/drugs, including alcoholic beverages.  Both plans intend to help realise the 
vision of a society free of substance abuse so that more attention can be focused on 
raising the quality of life of the poor and vulnerable and of developing the people to 
achieve their true potential. 
 
2.8.3.3 Lack of Physical Activity 
Physical activity has been defined as any bodily movement produced by skeletal 
muscles that require energy expenditure (WHO, 2015). Globally, it has been identified 
as the fourth leading risk factor for global mortality causing an estimated 3.2 million 
deaths globally (WHO, 2015).  This is mainly due to the changes which include 
revolutions in transportation, communication, workplace and domestic-entertainment 
technologies, which are occurring predominantly in urban settings.  The consequences 
of urban living and employment, coupled with easier access to public transport and a 
lack of basic infrastructure for exercising, have been associated with significantly 
reduced physical activity (Peer, 2013). 
 
Notably, even rural locations far from cities are increasingly becoming urbanised and 
mechanised. Even in developing regions, the physical activity patterns over the past 
few decades have shifted from labour-intensive lifestyles to more sedentary and less 
physically demanding activities. Technology and economic incentives tend to 
discourage activity; technology by decreasing the energy requirements for routine daily 
activities, and economics by greater reimbursements for sedentary than active work 
(Peer, 2013.) 
 
2.8.4 PSYCHOLOGICAL RISK FACTORS 
Dedkhard (2006) inking psychosocial factors with coronary heart disease are important 
in making causal inferences and therefore in designing preventive interventions. 
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Psychosocial factors may act alone or combine in clusters and may exert effects at 
different stages of the life course.  Psychosocial factors may affect health related 
behaviors such as smoking, diet, alcohol consumption, or physical activity, which in 
turn may influence the risk of coronary heart disease. 
 
The stressor may be something actually or potentially unpleasant. If it is perceived as a 
threat, a sensation of stress is felt. Thibodeau & Patton, 2002 cited in Dedkhard (2006) 
outlines that, stress coupled with stimuli leads to multiple bodily responses which could 
be regarded as mechanisms to increase our capacity for flight or fight – to run or to 
overcome. Physiological and psychological stress responses result from the sympathetic 
nervous system (SNS) directly and by the way of endocrine system. Numerous factors 
have effects on stress responses—individual physical and mental conditions, age, sex, 
heredity, socioeconomic status, and perceived experience of similar stressors. Stress 
can lead to not only many stress-related disorders such as gastritis, ulcerative, irritable 
bowel syndrome, rheumatoid, asthma, headache, anxiety, and depression, etc., but 
also chronic disease/illness such as CVD (Dedkhard, 2006). 
 
2.8.5 NON MODIFIABLE RISK FACTORS 
2.8.5.1      Family History, Age and Gender 
Among individuals, age and gender work hand in hand at causing variation in Blood 
Pressure.  As cited by Venter (2008), Torng, et al indicate that cardiovascular risk 
factors can potentially change with age, as is particularly the case with women; as the 
menopausal status is considered a cardiovascular risk factor (venter, 2008).  Post-
menopause is considered to occur between and during the age of 45 to 54 years of 
age. During this period blood pressure changes is natural in menopausal women, this is 
called the menopausal transitional period, where the SBP increases only slightly. Later, 
the lack of the oestrogen hormone causes both the SBP and DBP to increase. This 
change is lessened by oestrogen administration (Torng et al as cited by Venter, 2008). 
 
Furthermore, the risk of hypertension generally increases above the age of 35 years, 
but incidentally the age at which individuals experience urbanisation is also found to 
have a synergistic effect in precipitating a risk to cardiovascular disease. 
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Generally, aging brings about changes in arterial wall properties, such as elasticity 
(distensibility) and thus its buffering capacity (compliance). A decrease in arterial 
compliance causes elevated pulse pressure, leading to isolated systolic hypertension, 
detectible by non-invasive echo-tracking techniques (Venter, 2008).  When considering 
family history association, there are increased risks of first-degree blood relative has 
had coronary heart disease or stroke before the age of 55 years (for a male relative) or 
65 years (for a female relative). Findings by Pretorius, et al., (2011) in the Heart of 
Soweto Study suggested overall 145 patients (9.1%) reported a family history of 
stroke. 
 
2.8.6 ENVIROMENTAL RISK FACTORS 
2.8.6.1      Socio Economic Status 
An article by Jeemon, et al. (2009) states that, in developed countries socio-economic 
mortality differentials show that the low socio economic group suffer the highest 
mortality. Socio economic mortality differentials have been demonstrated using several 
indicators of social position representing occupational, educational and financial 
aspects. 
2.9   GOVERNMENT INITIATIVES AND GUIDELINES TO ADDRESS CVD  
Despite the growing burden of CVD and its potential catastrophic costs, there has been 
a limited health system response. This can be partially attributed to attention being 
focused on HIV/AIDS and other communicable disease; however government 
recognitions and initiatives are gradually beginning to be targeted at chronic disease 
more broadly. In 1996, the Directorate of Chronic Diseases, Disabilities and Geriatrics 
was established within the National Department of Health. In 2006, this directorate 
developed national guidelines for the management and control of NCDs. The intent was 
to facilitate a cross-sectorial response to the NCD burden in line with the World Health 
Organisation’s Action Plan for 2008 to 2013. In 2014, WHO issued strategic areas of 
work with government and partners for 2015-2020 in addressing the raging increasing 
of chronic non communicable disease which includes cardiovascular. One of the 
strategies outlined is on the importance of government to contribute effectively, 
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comprehensively and have multi-sectorial and multidisciplinary collaborations. This 
would be achieved through support to inter-ministerial actions on alcohol, tobacco and 
diet, the integrated school health program and the national health promotion (WHO, 
2014). The second strategy involves the capacity enhancement for government to 
implement public policies, strategies and regulations on the prevention and control of 
risk factors, furthermore, support evidence-based policies and strategies for public 
health problems which include the monitoring of the National NCD strategy and 
promote national guidelines on physical activity for health (WHO, 2014). Another 
strategic area of work in on strengthening health systems to manage chronic non 
communicable conditions through the inclusion of supporting the integrated Chronic 
Disease Management Model (ICDM) policies and integration of NCDs in national 
monitoring frameworks and ensuring access to medicine for chronic conditions (WHO, 
2014). 
2.9.1 Development of Guidelines 
Several disease specific guidelines for hypertension, chronic diseases of lifestyle (CDL) 
and for Type 2 Diabetes Mellitus have been developed in South Africa and across the 
world. These guidelines provide information on the management and control and 
include interventions that have been shown to be cost-effective in middle and lower-
income countries.  But available evidence suggests that primary prevention and 
management of common cardiac conditions is limited even with these guidelines “in 
place”. 
The South African guideline based on those of the European Society of Cardiology 
(ESC) recommends the assessment of risk in primary prevention using the updated 
Framingham risk chart. The four categories Framingham risk score as mentioned by 
Opie (2014) refer to the 10 year risk of any cardiovascular event, for the highest risk 
group (>30%), the LDL-C goal is 1.8 mmol/l, for the 15-30% risk group it is 2.5 mmol/l 
and for <15% risk goal is 3 mmol/l. 
The Department of Health has implemented standard treatment guidelines (STGs) and 
an Essential Drugs List (EDL) for treatment and management of CVD. Although drug 
supply remains problematic, these guidelines have been instrumental in getting 
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essential medicines to poorer and less accessible communities. Standard treatment 
guidelines enable more rational prescribing and the guidelines warrant more careful 
scrutiny. For example, hypertension treatment guidelines 2011 are based solely on the 
blood pressure level approach in diagnosis and management of hypertension except 
where diabetes is a co-morbid condition. 
2.9.2 Population wide interventions 
Population-wide approaches targets the entire population and addressing the causes 
rather than the consequences and targets individuals who are at high risk or aimed at 
persons with established disease (Gaziano, 2007). Tobacco Legislation is one example 
in South Africa, Tobacco Products Control Act which passed in 1993. This legislation 
prohibited and/or restricted smoking in public places, regulated the sale and advertising 
of tobacco products and warning labels on tobacco packages. Maredza, et al. (2011) 
noted that following this legislation, annual cigarette consumption fell by 33% from 
1993 to 2003. Consistent with this trend there has been a decline and stabilisation in 
the number of smoking-related CVD deaths.  Although the decline in CVD cannot be 
definitely attributed to the legislation, it is encouraging that the trend is in the expected 
direction.  
From both an effectiveness and cost-effectiveness perspective, the government 
increased tobacco taxes (also known as sin taxes) to 50% of the retail price of a pack 
of cigarettes in 1997. Taxes were gradually increased to 52% in 2002, where they now 
remain (Maredza, et al., 2011).  
Salt Reduction which is a potential new policy in South African, a government notice 
was issued in 2013 which provides regulations to the reduction of sodium in certain 
food stuffs. Maridza, et al. (2011) modern diets contain many times the minimum daily 
requirements of sodium, most of this coming from packaged foods and restaurant 
meals, making it difficult for individuals to control their intake. In South Africa, salt 
ingestion amongst all population groups exceeds international guidelines of <6g 
salt/day. Salt consumption is estimated 8 to 10 grams per person per day. Close to 
50% of this intake comes from non-discretionary sources, with bread as the single 
greatest contributor (WHO, 2014). Maridza, et al., (2011) emphasized that evidence 
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from around the world including South Africa, equates salt reduction with a drop in 
blood pressure and a lower risk of CVD events. Recent data from the United States of 
America indicates that as little as three grams per day decrease in salt intake could 
reduce annual healthcare costs attributable to cardiovascular disease by $10-24 billion 
annually. 
Another South African potential policy is the trans-fatty acid policy, which aims to 
reduce trans-fats present in certain processed and prepared foods currently on sale. 
Because trans-fatty acids significantly increase the risk of cardiovascular disease, the 
Maridza, et al., (2011) cited WHO at which it recommends that trans-fatty acids should 
be less than 1% of daily energy consumption. Currently, the oils in South African fast 
food outlets contain up to 25% of industrially produced trans-fatty acids and in most 
store-bought foods unless labelled otherwise contain trans-fats. 
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CHAPTER 3: METHODOLOGY 
3.1   STUDY DESIGN 
To meet the aim and specific objectives of the study, the researcher made use of a 
case- control study design to demonstrate casual association, in deed, the case- control 
study was an analytic research (etiology design).  Two groups of study participants, 
that is, the diagnosed and non-diagnosed CHD participants were recruited and 
interviewed from hospital Out Patients Department (OPD) and clinic/s about their socio-
demographic, physiological risk factors, behavioral risk factors, psychological risk 
factors and determinants of their CVD diagnoses. 
3.2 AREA OF STUDY 
The study was conducted at the Joe Gqabi District. In the district, there are three (3) 
sub districts, namely; Elundini Sub District, Maletswai Sub District and Senqu Sub 
District. Senqu Sub District (Map 1) was purposively selected as it has a larger 
population in the district of 135 676 in 2013 and an estimation on 136 349 in 2014 
(Massyn, et al., 2013). This is the main sub district with 20 clinics, 2 health posts and 
four hospitals. It is also a rural sub district with borders of Lesotho and Free State 
Province. The language preference in the sub district is isiXhosa, seSotho and isiHlubi. 
95% of the population in these areas are uninsured and use public health facilities.  
The sub district is affected by migrant and commuter labour, the proportion of 
households reporting at least one migrant household member to 18% of sub district 
households (Joe Gqabi District Five year Integrated Development Plan, 2013). 
According to the community survey 2007, the educational levels within Senqu Sub 
District are above the provincial average (34%) and a relative large proportion (10.8%) 
has no formal schooling and over 86% of the residents live in poverty.  
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Map 1: Joe Gqabi District, Eastern Cape: South Africa (BroadReach Health Care, 
2014) 
3.3  STUDY POPULATION  
The study population were all black rural adults who are 18 years and older attending 
the randomly selected public health facilities at the time of interview within the sub 
district, with a CVD (CHD, PAD, IHD, Hypertension) diagnoses and/ or are at risk of 
developing cardiovascular disease. Study participants were matched according to age 
and gender.  
3.4       SAMPLE SIZE CALCULATION 
As the prevalence (P) of CHD (Coronary Heart Disease) is not known in the Joe Gqabi 
District, Eastern Cape (No publication), we assume if the prevalence equals to 50% 
(0.50). Thus, the study sample size (Ni) was calculated using the following general 
formula (Hulley et al., 2007): 
Ni= 4x(Zα)2 x P (1-P)/ W2 
Where = constant, Z α  = the standard normal deviate for a two sided α, where (1-α) is 
the  confidence level (e.g, since α=0.05 for a 95% confidence level = 1.96, and W= 
total width of confidence interval = 0.20. Then the total of participants required was 
Ni= 4x3.84x0.50x0.50/0.225 
  =96 + round 100 participants. 
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3.5   SAMPLING 
Multistage sampling technique was used and simple random sampling at each primary 
unit for selecting from identified heath care facilities see (figure 3.1).  Therefore figure 
3.1 illustrates the total district sample, n=100.  
3.5.1  Unit 1 (Senqu Sub District) 
This was the first stage of sampling where one sub districts was identified, Senqu Sub 
District has a population of 135 676. The sub district was purposively sampled as it 
comprises of rural communities and isiXhosa is the main language spoken. 
3.5.2  Unit 2 (Hospitals) 
In the second unit there are 2 (two) public rural hospitals drawn from the sub district.  
Patients were purposively recruited from the Out Patients Department (OPD) 20 
(twenty) patients were randomly sampled from each hospital and therefore n=40 from 
unit 2. 
3.4.2  Unit 3 (Clinics) 
The last unit consisted of clinics which were randomly selected unit 1. Senqu Sub 
District has 20 clinics and due to its accessibility 6 clinics were randomly sampled. Out 
of the 6 clinics ten (10) study participants were randomly selected. Therefore n=60 
from unit 3. 
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Figure 3.1:  Study Sampling Process, Joe Gqabi District: Eastern Cape 
Target Population of Joe Gqabi District: Eastern Cape 
Eligible Population of Senqu Sub District (Rural) 
Sub District Hospital 
Sub 
District 
Clinic  
Sub District Hospital 
 
Randomly select 6 rural clinics 
Sub 
District 
Clinic  
Sub 
District 
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3.6   INCLUSION CRITERIA 
For the study one hundred (100) rural adult (18 years and older) participants were 
purposely recruited as per sample size calculations in all sampled eight (8) public health 
facilities as follows: 
Fifty cases (50) rural adults (18years and older) with a CHD diagnosis were recruited 
and matched with 50 controls with no CHD diagnosis. Participants were matched 
according to their age and gender.  
3.6.1   EXCLUSION CRITERIA 
All patients from the neighbouring country (Lesotho) and province (Free State) seeking 
medical help from the sampled sub district’s health facilities were excluded. Patients 
who were below 18 years were also excluded from the study. Pregnant or lactating 
women were also excluded from the study. Patients who were not able to speak due to 
the medical condition were also excluded in the study.  
 
3.7 DATA COLLECTION AND RESEARCH INSTRUMENT 
Data was collected through a standardised research questionnaire which consisted of 
questions that were divided into sections namely, demographic characteristics and 
socio economic factors, behavioural risk factors, family diagnosis, biological risk factors, 
socio demographic factors, psychological stressors and anthropometric measures or 
medical history. The standardised research questionnaire was formulated in both 
English and IsiXhosa.  
 The tool focused on: 
1. Demographic information of the responded 
2. Medical history at time of response 
3. Environmental factors of the responded (Socio economic factors) 
4. Biological determinants (genetic factors; ethnicity, age) 
5. Behavioural (smoking,  Lifestyle, diet, drinking) and Psychological factors of 
responded 
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3.8 ANTHROPOMETRIC MEASURES  
The anthropometric measurements were done by trained facility professional nurses 
who followed the Joint National Committee 7 (2004) guidelines for hypertension to 
classify study participants. Systolic blood pressure (SBP) ≥ 140mmHg and diastolic 
blood pressure (DBP) ≥ 90 mm Hg were defined as “hypertension”. Diabetes Mellitus 
was also measured using the American Diabetes Association (2014) guidelines. Waist 
circumference (WC) was measured over the abdomen between the costal margin. 
Measurements were taken to the nearest 0.1 cm using a non-stretchable standard 
tape; Weight was measured to the nearest 0.1 kg with the participants being barefoot 
and lightly clothed. Height was measured to the nearest 0.1 cm in the upright standing 
position with a stadiometer.  For this study, body weights were defined according to 
BMI as follows: normal weight 18.5–24.9 kg/m2; overweight 25–29 kg/m2; obesity ≥ 
30.0 kg/m2 (obesity class I 30.0 –34.9, class II 35.9 –39.9, class III ≥ 40 kg/m2). 
 
3.9 DATA ANALYSIS 
The dependent variable (CHD) was described in numbers (n=frequency) and 
proportions (%). The independent variable was characterised using frequency and 
proportions for categorical data, while the continuous information of the independent 
variables was expressed as mean ±standard deviation (SD). Tables and figures were 
used to highlight the summary findings of dependent and independent variable. 
Comparative analysis between cases and controls were carried out using uni-and multi-
variate analyses as described below. P-value <0.05 was considered to be statistically 
significant difference. All analyses were performed using Statistical Package for Social 
Science (SPSS) version 22.0 for windows (IBM SPSS Inc, Chicago, IL, USA) 
3.9.1 Univariate Analysis 
The proportions between (CHD: cases and controls) were compared using Pearson Chi-
Square test including linear-by-linear association). 
Student t-test was used to compare mean values of continuous variables between the 
two groups of the study population at identifying potential univariate risk factors of 
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CHD. The univariate association between some independent variable (such as: non 
modifiable risk factors, environmental risk factors, traditional risk factors, psychological 
risk factors and lifestyle risk factors) and CHD cases was calculated using odds ratio 
(OR) and 95% Confidence Interval (95 % CI). In model 1 entered all univariate risk 
factors were analysed in the logic regression analysis, whereas in model 2 hypertension 
was excluded in the logic regression analysis. 
3.9.2 Multivariate Analysis 
Multivariate Analysis from significant univariate to model 1 of multivariate analysis was 
used to identify the independent risk factors of multivariate risk of dependent variable 
of CHD in defining multivariate OR and their 95% CI using logistic regression models to 
avoid confounding factors adjusted. Some psychological risk factors were correlated 
with depression using simple correlation coefficient.    
3.10 ETHICAL CONSIDERATIONS 
Permission from the District Manager who is in charge of the selected public health 
facility was obtained and from the Epidemiology and Research unit if the Department 
(Appendix 1). Ethical approval was also obtained University ethics committee (Protocol 
number: 080/2014). (Appendix 2) All the relevant ethical conditions where adhered to 
at all times of the study.  
As this study involved conducting questionnaires, informed consent (as per WHO 
clinical research guidelines) was obtained both in writing and verbally and study 
objectives, background of the study, benefits, potential risk and voluntary participation 
where clearly stated or explained. The purpose of the study was explained to all the 
participants and they were assured about the confidentiality of the information and that 
their names were not recorded instead codes where used to identify their participation. 
Therefore, personal identifiers of patients such as names, telephone numbers and 
addresses of patients were not recorded. The consent form was in English and 
translated into isiXhosa which was a local language. The recruited study participants 
were also notified that, should they wish not to take part in the study their access to 
health care was not compromised and will still receive medical care. (Appendix 3-4) 
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CHAPTER 4: RESULTS 
This chapter summarises findings with special reference to most important and 
significant results. Both descriptive and inferential data are presented. Risk factors are 
also presented in both univariate analysis and multivariate analyses 
4.1 SOCIO DEMOGRAPHIC FACTORS/ PROFILES 
Table 4.1. Socio demographic characteristics among patients with CHD and controls 
  Case   Control  
Characteristic n  % n  % 
Age Group       
<30 1  2 20  40 
30-34 5  10 5  10 
35-39 5  10 6  12 
40-49 1  2 4  8 
50+ 38  76 15  30 
Gender       
Males 17  34 11  22 
Females 37  74 39  78 
Marital Status       
Married 41  67.2 20  37.8 
Non Married 9  23.1 30  76.9 
Residence       
Semi urban - 
Township 
36  72 16  32 
Remote rural 
areas 
14  28 34  68 
 
As CHD cases were matched with controls for gender and ages, females predominance 
is (37 women and 17 men in CHD cases versus 39 women and 11 men in controls; 
P=0.181) and older ages (61.7±19.1 years in CHD cases versus 62.4 ±19.6 years in 
controls; P= 0.857) were comparable between the study groups. The proportion of 
CHD cases (67.2% n=41/61 married and 23.1% n=9/39 non married) were 
significantly (P<0.0001) different from those of controls (37.8% n=20/61 married and 
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76.9% n=30/39 non married). Indeed, compared with non-married, the married status 
conferred 6.8-fold higher risk of CHD (OR= 6.8; 95% CI 2.7-17.1; P<0.0001) 
 
The percentages of CHD cases varied significantly (P<0.0001) and unequally across the 
settings of the participants. Indeed, 52% (n=52) and 48% (n=48) out of all 
participants were living in semi-urban areas including township and remote rural areas 
(Figure 4.1) , respectively and semi-urban areas including (CHD=69.2%, OR= 5.5; 
95% CI 2.3-12.9; P<0.0001) conferred significant 6-Fold higher risk of CHD than 
remote rural areas (CHD= 29.2%).  
There was significant (P for trend =0.0002) but negative dose-responses relationship 
between the proportions of CHD cases and the educational levels. In this biologic 
gradient, the highest, intermediate, and lowest rates of CHD cases more observed in 
Illiterate-Primary, High School, and College and University, respectively. 
 
4.2 CORONARY HEART DISEASE and OTHER CARDIOVASCULAR 
DISEASE 
All CHD cases (100%) had elevated serum Total Cholesterol. The numbers (Table 4.2) 
and frequencies (Figure 4.1) of co-morbidity of CHD with other CVD cases such as 
Peripheral Artery Disease (PAD), Cardiac Failure, and CVA/Stroke. On average 1/5 CHD 
case was clustering with PAD, cardiac failure and CVA/ Stroke, respectively. 
Table 4.2 Frequencies (n) of the other CVD among cases of CHD 
Variables of interest Cases 
n 
Controls 
n 
Peripheral Artery Disease 10 0 
Cardiac Failure 9 0 
CVA/Stroke 8 0 
CHD only 23 0 
Source: Data using SPSS version 22.0 
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Figure 4.1. Distribution of proportions of CHD cases by Peripheral Artery Disease, 
Cardiac Failure CVA/Stroke status 
 
Source: Data using SPSS version 22.0 
 
Table 4.2 (b) Distribution of proportions of CHD cases by Peripheral Artery Disease, 
Cardiac Failure CVA/Stroke status 
 CHD 
% 
Control 
% 
Peripheral Artery Disease 20 0 
Cardiac Failure 18 0 
CVA/Stroke 16 0 
CHD only 46 0 
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4.3 SOCIO ECONOMIC STATUS 
There was no significant (P=0.681) effect of the socio economic status on CHD cases 
rates as follows: 40% (n=6/15) among not employed, 50% (n=16/32) in government 
subsidy, and 52.8% (n=28/52) among employed participants. 
4.4 ANTHROPOMETRY 
Table 4.3 presents the comparisons the anthropometric parameters between CHD 
cases and controls. The mean values of height were similar (P>0.05) between CHD 
cases and controls, whereas the mean levels of weight, BMI and waist circumferences 
(WC) were significantly (P<0.05) highest in CHD cases than those from controls. 
Table 4.3 Comparisons of levels of selected anthropometric parameters by the study 
population 
Variable of  
interest 
CHD cases 
Mean ±SD 
Controls  
Mean ± SD 
P-value 
 
Height (m) 1.587±0.0097 1.607±0.125 0.373 
Weight (kg) 80.4±20.2 68±10.5 <0.0001 
BMI (kg/m2 32.5±9.8 26.8±5.8 <0.001 
WC (cm) 100.4±20.5 81.1±15.7 <0.0001 
Source: Data using SPSS version 22.0 
There was a significant (P for trend =0.005) and positive linear association between 
increasing rates of CHD cases and increasing levels of BMI (Figure 4.2). Indeed 9/10 
and 2/3 of CHD cases were in obesity class 3 and Obesity Class 2, respectively, 
whereas 4/10 of CHD cases were observed in overnight, absence of obesity and 
Obesity Class 1  
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Figure 4.2 Distribution of proportions of CHD cases by the nutritional status 
 
Source: Data using SPSS version 22.0 
Then, in all participants Figure 4.3(a) considered ¼ people with Severe Obesity for 
Obesity Classes 2-3 were contrasted with a sub group including normal weight-
Overweight-Obesity Class 1. The proportions of CHD were significantly common in case 
of Severe Obesity (CHD=76% n= 19/25, OR=4.5; 95% CI 1.6-12.6; P= 0.003) than in 
sub group of Normal- Overweight- Obesity Class 1 (CHD= 41.3% n=31/75)  
Figure 4.3(a) Distribution of participants by counts of severe obesity 
  
Source: Data using SPSS version 22.0 
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Figure 4.3(b) Distribution of participants by counts of Severe 
 
Source: Data using SPSS version 22.0 
The proportion of CHD cases were significantly commonest in the presence of IDF 
abdominal obesity (61.5% n=32/52, OR=2.7; 95% CI 1.2-6; 6=0.016) than those 
among controls (37.5% n= 18/48). 
Table 4.3 (c ) Distribution of participants by counts of Severe Obesity 
Distribution Cases 
n 
Controls 
n 
Severe Obesity in Classes 2-3 19 6 
Normal Weight-Overweight-
Obesity class 
31 44 
 
4.4.1  Blood Pressure components and disorder 
The mean values of SBP, DBP, and Pulse Pressure (PP) of CHD cases were significantly 
(P<0.0001) highest than those of controls (Table 4.4). 
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Table 4.4 Comparisons of mean levels of selected BP components by the study 
population 
 Variable of  
interest 
CHD cases 
Mean ±SD 
Controls  
Mean ± SD 
P-value 
 
SBP (mmHg) 138.3±21.8 116±14.2 <0.0001 
DBP (mmHg) 79.6±17.1 68.6±8.8 <0.0001 
PP (mmHg) 58.9±21.4 47.5±12.4 <0.002 
 SBP= Systolic Blood Pressure, DBP= Diastolic Blood Pressure, PP= Pulse Pressure 
(Source: Study data using SPSS version 22.0) 
In considering BP control, there was a significant (P<0.0001) and biologic gradient 
linear positive association of lowest, intermediate, and highest CHD rates with no 
hypertension, controlled systolic hypertension, and uncontrolled hypertension (Figure 
4.4). 
Figure 4.4 Distribution of proportions of CHD cases by SBP control 
levels
 
Source: Study data using SPSS version 22.0 
54 
 
There was also a significant (P<0.0001) variation of CHD rates DBP control levels: the 
lowest, intermediate, and highest proportions of CHD cases in absence of hypertension, 
controlled diastolic hypertension, and uncontrolled diastolic hypertension (Figure 4.5) 
Figure 4.5 Distribution of proportions of CHD cases by DBP Control level 
 
Source: Study data using SPSS version 22.0 
4.4.2 Metabolism of Glucose 
The mean concentration of fasting plasma glucose was significantly (P=0.003) higher in 
CHD cases (FPG= 6.8±3.7 mmol/L) than that for controls (FPG= 5.2±0.8 mmol/L). 
Thus, CHD was significantly more frequent in the presence of T2DM (90% n=18/20; 
P<0.0001) than in the absence of T2DM. Indeed, the presence of T2DM conferred 14-
Fold highest risk of CHD (OR=13.5; 95% CI 2.9-62.2; P<0.0001) than the absence of 
T2DM. 
The significant (P for trend <0.0001) increases in CHD rates from the absence of 
T2DM, through newly diagnosed T2DM, known and controlled T2DM, to known  and 
uncontrolled T2DM is demonstrated in Figure 4.6. 
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 Figure 4.6 Distribution of percentages of CHD by FPG control levels 
 
Source: Data using SPSS version 22.0 
4.5 LIFESTYLE 
Inactive participants (54.2% n=26) had similar (P=0.423) proportions of CHD cases in 
comparisons with those active participants (46.2% n=24). 
Cigarette smokers had also similar (P=0.106) rates of CHD cases (36% n=9/25) in 
comparison with those of non-smokers (54.7% n= 41/75).  
4.6 DIET 
Table 4.5 presents associations between diet patterns, lifestyle and CHD in the study 
population. Paradoxically, there was no significant association between amount of fried 
foods, vegetables, fruits, coffee and CHD. However, the risk of CHD was multiplied by 4 
times (OR= 4.1; 95% CI 1.6-10.6) and 2 times (OR=2.2; 95 CI 1-5) in case of no 
intake of starchy foods and excessive alcohol intake, respectively. 
n= 28/73      3/16       8/10    11/11 
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Table 4.5 Associations between Fried foods, Vegetable intake, Fruit intake, Coffee 
intake, Alcohol intake and CHD 
Variable of 
 interest 
CHD 
n (%) 
Controls 
n (%) 
P-value 
Fried foods   0.466 
   < once/week 22/28 (57.9) 16/28 (42.1)  
   2-3 times/week 23/51 (45.1) 28/51 (54.9)  
   Everyday 5/11 (45.5) 6/11 (54.6)  
Vegetables   0.217 
    < once/week 10/14 (71.4) 4/14 (28.6)  
    2-3 times/week 34/74(46) 40/74 (54.1)  
    Everyday 6/74(50) 6/74 (50)  
Fruits   0.640 
     No 39/76(51.3) 37/76 (48.7)  
     Yes 11/24(45.8) 13/24 (54.2)  
Coffee   0.214 
    <once/week 16/29 (55.2) 13/29 (44.8)  
     1-4 cups/ Day 28/63 (44.4) 35/63 (55.6)  
    ≥5 cups/ Day 6/8 (75) 2/8 (25)  
Drinks   0.048 
     Excessive alcohol 23/37 (62.2) 14/37(37.8)  
     Moderate alcohol and 
soft       
     drinks 
27/63 (42.9) 40/63(63.5)  
Fiber/Starchy   0.002 
      No 22/30 (73.3) 8/30(26.7)  
      Yes 28/70 (40) 42/70(60)  
Tobacco Use   0.106 
      Yes 9/25 (36) 16/25(64)  
      No 4/75 (54.7) 71/75(94.7)  
 Source: Data using SPSS version 22.0 
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4.7 HEREDITY/FAMILY HISTORY OF RISK FACTORS OF CVD 
Table 4.6 shows associations between heredity/ family history of risk factors of CVD 
and CHD cases in the study population. There was no significant (p>0.05) associations 
between Family History of CVD, Family or relationship dispute, Father CVD, Mother 
CVD, Grand Parents CVD, Extended family CVD, Hypertension in family, CVA (Stroke) in 
family and CHD cases. However, there were significant associations between siblings 
CVD, cardiac failure in family, CHD in family and CHD cases 
However, highest risk of CHD was significantly conferred by siblings family of CVD 
(87.5% n=14/16, OR= 9.3; 95% CI 2-43.7;P<0.001 in yes  versus 42.9% n=36/84 in 
no), cardiac failure in Family (82.4% n=14/17, OR = 6.1; 95% CI 1.6-22.8; P=0.003 in 
yes versus 43.4% n=36 183 in no), and CHD in Family (90% n= 9/10, OR= 10.8; 95% 
CI 1.3- 88.5; P=0.008 in yes versus 45.6% n=41/90 in no);   
Table 4.6 Associations between Heredity/ Family history Of Risk factors Of CVD and 
CHD cases 
Variables of 
Interest 
CHD 
n (%) 
Controls 
n (%) 
P- Values 
Family history of CVD   0.161 
   Yes 27/47 (57.4) 20/47 (42.6)  
   No 23/53 (43.4) 30/53 (56.6)  
Family/ relationship 
dispute 
  0.338 
   Yes 4/11 (36.4) 7/11 (63.6)  
   No 46/89 (51.7) 43/89 (48.3)  
Father CVD   0.799 
   Yes 9/19 (47.4) 10/19 (52.6)  
   No 41/81 (50.6) 40/81 (49.4)  
Mother CVD   0.585 
  Yes 7/16 (43.8) 9/16 (56.2)  
   No 43/84 (51.2) 41/84 (48.8)  
Grand Parents   0.585 
   Yes 9/16 (56.3) 7/16 (43.8)  
   No 41/84 (48.8) 43/84 (51.2)  
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Variables of 
Interest 
CHD 
n (%) 
Controls 
n (%) 
P- Values 
Extended Family   0.315 
   Yes 0/1 (0) 1/1 (100)  
   No 50/99 (50.5) 49/99 (49.5)  
Hypertension Family   0.834 
    Yes 17/35 (48.6) 18/35 (51.4)  
    No 33/65 (50.8) 32/65 (49.2)  
CVA (stroke in family)   0.629 
   Yes 10/22 (45.5) 12/22 (54.5)  
   No 40/78 (51.2) 38/78 (48.7)  
Siblings   <0.001 
    Yes 14/16 (87.5) 2/16 (12.5)  
     No 36/83 (43.4) 47/83 (56.6)  
Cardiac failure in family   0.003 
     Yes 14/17 (82.4) 3/17 (17.6)  
     No 36/83 (43.4) 47/83 (56.6)  
CHD in family   0.008 
    Yes 9/10 (90) 1/10 (10)  
    No  41/90 (45.6) 49/90 (54.4)  
Source: Data using SPSS version 22.0 
 
4.8 PSYCHOLOGICAL FACTORS 
Out of a huge number of psychological factors, almost all factors were not significantly 
associated with CHD cases  
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Table 4.7 Comparisons of proportions of neutral psychological factors by the study 
population 
Source: Data using SPSS version 22.0 
However, numbers of sexual difficulties, Depression, Accelerated Heart rate when upset 
and inability to control breathing were higher in CHD cases than in controls.  
 
 
 
Variables  
of Interest 
CHD cases 
n (%) 
Controls 
n (%) 
P- 
Value 
Death of spouse 12(24) 7(14) 0.202 
Death of a friend 11(22) 5(10) 0.102 
Death of a family 25(50) 20(40) 0.315 
Illness in family 16(32) 13(26) 0.509   
Disputes in family  4(8) 7(14) 0.338 
Divorce/separation 2(4) 2(4) 0.691 
Anxiety 36(72) 37(74) 0.822 
worry 41(82) 41(82) 0.602 
Panic 39(78) 38(76) 0.812 
Felling uneasy 35(70) 30(60) 0.812 
Sadness 37(74) 40(80) 0.476 
Hopelessness 31(62) 38(76) 0.130 
Apathy 31(62) 35(70) 0.398    
Loneliness 32(64) 30(60) 0.680  
Social interest 27(54) 35(70) 0.100 
Angered 34(68) 34(68) 0.583 
Frustrated 38(76) 38(76) 0.373                            
Resentment 29(58) 30(60) 0.839 
Hostility 34(68) 30(60) 0.405 
Irritability 36(72) 31(62) 0.288 
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Table 4.8 Association between quality life and stress factors and CHD 
Variables of 
Interest 
CHD 
n (%) 
Controls 
n (%) 
P value 
Accelerated heart 
rate when upset 
  <0.0001 
     Yes  43/54 (79.6) 11/54 (20.4)  
     No 7/46 (15.2) 39/46 (84.8)  
Recurrent feeling of 
unease 
  0.295 
     Yes 35/65 (53.8) 30/65 (46.2)  
      No 15/35 (42.9) 20/35 (57.1)  
Inability to control 
breathing 
  <0.0001 
      No 39/59 (66.1) 20/59 (33.9)  
      Yes 11/41 (26.8) 30/41 (73.2)  
Depression   <0.0001 
       Yes 47/78 (60.3) 31/78 (39.7)  
       No 3/22 (13.6) 19/22 (86.4)  
Personal Difficulties   0.753 
       Yes 1 /2 (50) 1/2(50)  
       No 49/98 (50) 
 
49/98 (50) 0.079   
Sexual Difficulties    
     Yes 3/3 (100) 0/3 (0)  
      No 47/97 (48.5) 50/97 (51.6)  
Source: Data using SPSS version 22.0 
In all participants, CHD cases, and controls, the burden of Mental Health was defined 
by psychological stress and Personalities Disorders such as Worry, Sadness, Panic, 
Breathing Control, Anxiety, Feeling of Unease, Hopelessness, Apathy, Loneliness, 
Frustrated status and Depression. Moreover, Frustrated status (r = 0.314; P< 0.001), 
Loneliness (r= 0.231; P=0.021), Feeling of unease (r= 0.268; P=0.001), Accelerated 
Heart rate (r= 0.236; P= 0.018), and inability to control breathing (r=0.294; P= 0.003) 
were significantly linked with Depression. Demonstrates the collinearity between 
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Frustrated status, no control of breathing, Loneliness, Accelerated heart rate, Unease 
and Depression (Distribution of proportions of some psychological factors within sub 
group of the presence of Depression in all participants). 
4.9 INDEPENDENT RISK FACTORS OF CHD USING MULTIVARIATE ANALYSES 
In considering all significant univariate risk factors of CHD using multivariate logistic 
regression analysis and adjusting for confounding factors (socio demographic, heredity, 
obesity, psychological factors, T2DM factors) (Model 1, only uncontrolled systolic 
hypertension and personal history of hypertension were significantly and independently 
associated with CHD cases (Table 4.9).  
Table 4.9 Independent Risk Factors of CHD in Model 1 
 B SE Wald Adjusted OR 95%CI P 
Independent Variables 
Uncontrolled  
hypertension 
      
Personal History of 
hypertension  
4.549 0.877 26.875 95 (16.9-128) <0.0001 
Hypertension 
 Ht 
4.277 0.773 30.625 72 (15.8-133) <0.0001 
Ht= Hypertension. Source: Data using SPSS version 22.0 
When Model 2 at not entering collinearity variables (Hypertension components) and 
after ad justifying for confounders (not in the equation such as Depression, Ischemic 
Heart, History in Family, Educational level, personal history of T2DM, control, intake of 
soft drinks versus Excessive Alcohol, CVD History in siblings, Cardiac Failure History) 
using multivariate logic regression analysis, married, personal history of T2DM, no 
intake of starchy foods, plenty of fibre, semi-urban areas including township and severe 
obesity were identified as the most important significant independent risk factors of 
CHD (Table 4.10). 
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Table 4.10 Most important and Independent Risk Factors of CHD in Model 2 
 B SE Wald Adjusted OR (95%CI) P 
Independent 
Variable 
      
Marital Status       
Married 1.902 0.581 10.727 6.7  (2.2-20.9) <0.001 
Personal 
History of 
T2DM 
  
Yes 1.829 0.979 3.491 6.3 (1.1-12.4) 0.049 
No Intake of 
starchy foods 
plenty of fibre 
  
No 1.277 0.649 3.866 3.6  (1.01-12.8) 0.049 
Semi-Urban 
with Township  
1.865 0.589 10.009 6.5 (2-20.5) 0.002 
Severe Obesity 1.752 0.692 6.421 5.8 (1.5-22.4) 0.011 
Constant -3.165 0.672 22.195    <0.0001 
Source: Data using SPSS version 22.0 
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CHAPTER 5 
5.1. DISCUSSSION 
The study was to assess risk factors of coronary heart diseases among rural adults in 
Joe Gqabi: Eastern Cape Province of South Africa. To achieve this aim, we assessed the 
demographic profile, the anthropometric risk factors, the behavioural determinants of 
cardiovascular diseases (diet, smoking habits, alcohol use and physical activity) and the 
environmental risk factors and psychological risk factors. 
Three categories of risk factors examined were: Non modifiable risk factors, Modifiable 
risk factors and environmental risk factors. Non Modifiable risk factors comprised of 
age, gender and family history of CVD; Modifiable risk factors being further sub divided 
along behavioural risk factors, and physiological risk factors and environmental risk 
factors included socio economic status and psychological risk factors.  
5.1.1 Demographic profile 
Demographic characteristics of the sampled population are stratified by age, gender, 
marital status, educational status. Finding of this study demonstrated that gender had 
no positive relationship with risk factors of CHD; however when considering age, family 
history and marital status, age showed a slight significance, these finding were 
consistent with evidence from previous prospective reports where the increase risk for 
CVD continued sharply until the age of 60 to 65 years.  During the current study a 
large proportion of participants were females. Out of the represented number of males, 
a large proportion was above the age 40. The 2013 SANHANES-1 study demonstrated 
the gender and age disparity where the mean systolic blood pressure for males was 
significantly higher than that for females, however, the diastolic blood pressure did not 
differ significantly by gender. Mean systolic blood pressure was reported to have 
increased progressively with increasing age especially in the over 65 years of age group 
(Shisana, et al.,2013)  in the current study, when compared between groups, age 
variations between males and females were still substantial with older female counter 
parts dominating. Data extracted from the census 2011, generally outlines that within 
the sampled population there are more females than males and a large proportion 
within the population has only primary level education (Statistics South Africa, 2011). 
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Akinboboye, et al. (2003) had observed that, gender related differences among black 
people in the prevalence of CVD had not been clearly shown in Sub Saharan Africa. 
Differences on levels of education among groups were also demonstrated, were a large 
proportion of participants between cases and controls indicated that they had no formal 
schooling or a low level of literacy. However data demonstrated a negative effect to 
risk factors. These findings therefore ruled out the educational risk factors as potential 
risk factor and determinant of cardiovascular in the rural area. This finding was also 
corroborated with the study done in Nigeria by Oguoma, et al. (2015) were it was 
observed that, education was not a protective factor against CVD risk factors, as trends 
showed that individuals with no primary education with those with at least a university 
education had higher prevalence of CVD risk factors than those with primary and 
secondary education. 
During the study, it was demonstrated that indeed married participants as compared to 
the unmarried participants were at higher risk of CHD. Even though percentages of 
CHD cases varied significantly and equally across settings of the participants, it was 
evidently proven that participants who reside in semi urban participants had a higher 
risk of CHD than those residing in remote rural areas.  
Family History is widely recognised as a reliable tool in predicting the risk of NCDs in 
individuals as it includes genetic characteristics and shared environmental  as well as 
behavioural factors (Shisana, et al., 2013). The findings of the study demonstrated 
that, there was no significant association between family history of the mother, father, 
grandparents and extended family. However the highest risk was of CHD was 
significantly conferred by siblings where there was a high odds ratio. The same results 
were observed by Dedkhard (2006) as it was demonstrated that family history of CHD 
was not an independent risk factor of CHD in rural Thai women despite previous 
studies from the Western countries indicating that family history was a significant 
contributor in women. Contrary to this, Shisana, et al., (2013) on the SANHANES-1 
study outlined that the self-reported rates of family history of NCDs highlighted that the 
rate of self-reported family history of all of the assessed conditions was highest among 
respondents in urban formal settings. Free State Province, Western Cape Province, 
Eastern Cape Province and Northern Cape Province had the highest rates of self-
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reported family history. The rate of self-reported family history of high blood pressure, 
stroke, high blood sugar and heart disease was highest among Indians, while coloureds 
had the highest self-reported family history rate of stroke and Black Africans on the 
other hand, had the lowest self-reported of high blood pressure, stroke, high blood 
sugar and heart disease (Shisana, et al., 2013). 
5.1.2   Anthropometric risk factors 
For the study, following categories on the anthropometric measures were examined: 
weight, waist, height, blood pressure (systolic blood pressure, diastolic blood pressure), 
diabetes mellitus and body mass index.   
The study findings demonstrated that, there was almost no association on levels of 
height between cases and controls even though the approach did not quite achieve 
significance, however, when compared to the mean levels of weight, BMI and waist 
circumferences, data shows that there was a strong trend of significance which seemed 
to be highest in CHD cases than those from controls. When documenting BMI levels as 
single a variable, the study data demonstrated a positive linear association between 
increasing rates of CHD cases and obesity, where cases conferred a higher odds ratio 
on increasing levels of obesity as compared to controls. Several studies have been 
consistent in demonstrating obesity as a causal factor in CHD morbidities and 
mortalities. Bassuck, et al. (2008) demonstrated a strong linear association between 
excess weight and CHD. Furthermore, in a study done Oguoma, et al. (2015) in 
Nigeria, higher BMI levels in females than males were demonstrated, this was 
corroborated with other studies done Durban and Tanzania confirmed that more 
females showed a higher BMI levels than females (Akinboboye, et al., 2003). In the 
current study, the proportion of abdominal obesity was prevalent and showing a 
significant and conferring a slightly high odds risk exposure.  Evidently, in the current 
study, obesity was a prevalent risk factor. Previous studies have documented 
development of obesity to be mostly prevalent in urban settlements, were the 
transition has been linked to urbanization. A study by Mathenge, et al. (2010) 
demonstrated higher obesity prevalence in urban location compared to rural Kenya.  
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Hypertension was the most prevalent CHD risk factor in the current study just as have 
been reported by many other studies carried out the country. Previous studies carried 
out in South Africa have shown that high blood pressure contributes to a considerable 
burden of cardiovascular disease. The distribution of hypertension prevalence among 
cases and controls demonstrated differences, a high recording of hypertension in the 
study was documented among CHD cases were mean values of systolic blood pressure, 
diastolic blood pressure and pulse pressure showing a linear positive association of 
lowest, intermediate and highest CHD rates when compared to the controls. In the 
Heart of Soweto study, 56% of the study participants were hypertensive (Silwa, et al., 
2008) and a study commissioned by Van Zyl, et al. (2010) also found that the 
prevalence of self reported hypertension was 63.1%. When comparing the two studies 
commissioned in the country, and the prevalence of hypertension in the current study it 
then demonstrates hypertension as a major risk factor of CHD in rural areas. 
The second major CHD risk factor in this study is the prevalence of diabetes among 
study participants, which was demonstrated to be significantly higher among cases 
than controls. Data demonstrated a frequent significant presence of type 2 diabetes 
mellitus that conferred the both highest risk and odd ratio among the cases. Van Zyl, et 
al. (2010) in the study commissioned within rural Free State towns, found that the 
prevalence of diabetes high at 10.8% and explained it problematic within those 
communities, Alberts, et al. (2005) also demonstrated a high prevalence of diabetes in 
their study commissioned among Blacks in rural Limpopo. A study done in Ethiopia, 
demonstrated a consistency with the current study were finding revealed a high 
predominance of type 2 diabetes among sampled patients and had an escalating 
number of patients of patients with diabetes that previously (Alemu, 2015). 
5.1.3   Behavioural determinants of cardiovascular diseases  
In assessing behavioural determinants, diet, smoking habits, alcohol use and physical 
activity risk factors were classified under modifiable risk factors and were assessed 
among respondents.  
There is overwhelming evidence that smoking, alcohol use and physical activity are 
important determinants of coronary heart disease, and prospective case control studies 
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have showed a strong graded relative risk relationship (Kromhout, 2002). In comparing 
alcohol and tobacco use, the current study data showed that excessive alcohol intake 
was commonest CHD cases and carried a slightly high odd ratio, however, smoking 
patterns among both groups also carried similar patterns where there was no statistical 
significance. Current studies done in the country illustrate that the prevalence of 
alcohol is more common in urban areas than rural settlements (Van Zyl, et al., 2010); 
however this study demonstrated the contrary to that. According to the study done by 
Kromhout, et al. (2002) a strong association between smoking and coronary heart 
disease was observed where the relative risk was five times more between smokers 
and non smokers. When illustrating physical activity, the current study demonstrated 
that inactive respondents had similar proportions with those active respondents, and 
therefore, physical activity was not decisively significant or there was no difference in 
statistical significant. Contrary to the findings, globally, physical inactivity and alcohol 
use are recognised as among leading risk factors of mortality and are responsible for 
NCD risks such as coronary heart disease, type 2 diabetes (Shisana, et al., 2013). The 
current study applied self-reported data during data collection, which was in turn a 
limitation for the study analysis as the findings differed from the studies conducted. In 
2003, an international study on physical activity. Completed in 51 countries including 
South Africa, used self-reported data to confirm the finding of low levels of physical 
activity among South Africans 
 
Healthy eating forms the basis for achieving and maintaining cardiovascular health. 
Finding from this study illustrated the effects of diet such as fried foods, fruits, 
vegetables and coffee had on the risk factors of coronary heart disease. Current study 
displayed frequent difference on intake of starchy food as the odds ratio was slightly 
high among CHD cases. Interestingly, prospective studies do show a beneficial effect of 
a similar magnitude of combined fruit and vegetable intake on the incidence of 
coronary heart disease, nonfatal myocardial infarction, stroke, coronary surgical 
procedures, and cardiovascular disease related death (Din, 2002). A study conducted 
by Reddy, et al., (2007) noted that, among urbanised populations who are also 
referred to as “early adopters”, urbanization leads to lifestyle changes, resulting to an 
increased consumption of energy rich foods and in energy expenditure and loss social 
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support that is available for rural societies. Therefore the current study finding 
corroborated with other studies done 
5.1.4   Environmental risk factors and psychological risk factors  
The findings of this study demonstrated that there was no relationship on the socio 
economics status which included income levels among participants and CVD risk 
factors.  However, in Nigeria, few reports were found on the association between socio 
economic status and cardio-metabolic syndrome, high prevalence of cardiometabolic 
risk factors were found in high socio economic status groups that in low socio economic 
groups (Oguoma, et al., 2015). A study among rural Thai women also corroborated 
that socio economic status including educational levels and low family income were 
negatively and significantly related to the severity of CHD (Dedkhard, 2006). 
Interestingly, the INTERHEART study also attested to the trends in socio economic 
status, where data demonstrated that, among the more educated and wealthier sector 
of society the risks are much higher than in poor sector (Steyn et al., 2005). 
Socio economic status is a predictor of CHD and its risk factors, the nature of this 
relationship varies dependent on the economic development of the countries (Oguoma, 
et al., 2015). Evidently there is a relationship between socio economic status and risk 
factors in adult population in high income countries, even though the trend differs in 
low income countries were lower socio economic status is a potential marker for poor 
health outcomes.  
When considering psychological risk factors among both sampled groups, the study 
demonstrated that almost all psychological factors observed data demonstrated no 
association to coronary heart disease however sexual difficulties, depression, 
accelerated heart rate when upset and uncontrolled breathing were observed to be 
higher among cases. In this study, depression was significantly linked to frustrated 
status, loneliness, feeling of unease and no control of breathing.  Interestingly, this was 
not corroborated by Gupta, et al. (2012) in the study it was noted that, there was no 
prevalent association of depression among lower socio economic status participants 
despite psychological stress being greater in low educational status individuals.  
69 
 
As the study involved collection of data relating to the demographic profile, individual 
characteristics related to major risk factors of CHD, medical history and anthropometric 
profile. A clear demonstration on the presence of major risk factors such as high waist 
circumference, high BMI, elevated blood pressure, elevated blood glucose was 
presented in the current study which all contribute to the development of CVD related 
diagnosis was prevalent in this rural population. The INTERHEART Africa study showed  
that only five risk factors account for 89.2% of the risk for an initial CVD, that is, 
tobacco use, self reported hypertension, diabetes, abdominal obesity (Steyn et al., 
2004). However, dietary or lifestyle behavior modification, productive physical activity 
and weight reduction and increase in the level of literacy were proved to be an 
important issue in the prevention and management of cardiovascular disease. In a 
study by Gupta, et al. (2012) it was observed that lower educational and 
socioeconomic status subjects unhealthy lifestyles despite them being major 
determinants of increased cardiovascular risk. 
5.2   CONCLUSION 
CHD is a multifactorial condition among poor black Xhosa people. Therefore major risk 
factors of CHD in the diagnosed cases are uncontrolled systolic blood pressure, 
personal history of hypertension, personal history of T2DM, marriage, no intake of 
starchy foods/ plenty of fibre, semi urban/township, and severe obesity. However, 
undiagnosed controls showed a CHD risk in diet patterns.  
5.3   LIMITATIONS 
In the district, there is a gross shortage of clinicians, this challenge was profound 
during this study. Joe Gqabi District bears the burden of these shortages as the district 
has difficulties in attracting and retaining enough clinical staff to provide health service. 
Availability and lack of medical equipment is another challenge that affected this study 
as some anthropometric measurements were not taken in all research participants. The 
study was also affected by access to public transport which became a potential bias to 
the sample as it favoured those who can afford and not walk long distances.  
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5.4   RECOMMENDATIONS 
The risk factors of CHD among black Africans in rural communities are still obscure and 
demand more research. Our country is in dire need of a comprehensive action plan or 
program to help in reduction and elimination of increasing chronic epidemic of 
cardiovascular diseases. More research is needed on risk factors for CVD, and this 
study can be used as a baseline for Joe Gqabi District. 
Health promotion measures are key components in increasing life expectancy among 
black people, therefore, educational programmes should be speedily implemented to 
educate rural populations with regard to the importance of balanced nutrition, 
increasing physical activity, early detection, adherence to treatment, stop smoking and 
reduce excessive alcohol consumption.  
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APPENDIX 4: INFORMATION SHEET  
 
Description of the research and your participation 
 
You are invited to participate in a research study conducted under supervision of Dr C.  R. 
Sewani- Rusike and I am a MPH student at the Walter Sisulu University. 
 
The purpose for this study is to obtain an in depth understanding of the risk factors and 
determinants of rapidly growing global epidemic, to influence policy frameworks and 
prevention strategies.  
 
Voluntary Participation 
 
Your participation in this research is entirely voluntary, it is your choice whether to 
participate or not. Whether you choose to participate or not, the facility (clinic or hospital) 
service will continue and nothing will change. You may change your mind later and stop 
participating even if you agreed earlier and will not be penalized in any way should you 
decide not to participate or to withdraw from this study.  
 
Should you agree, your participation will involve one questionnaire interview with you 
which will take about 30 minutes and focusing of your knowledge and opinions of 
cardiovascular diseases. You are requested to honestly respond to the interview questions  
 
Risks and discomforts 
 
Whilst participating in this study, there are no anticipated risks or harm that you may 
sustain. The tool (questionnaire) used in the study focuses on your behavioural and 
societal questions and will not cause any discomforts.   
 
Potential Benefits 
 
The study unfortunately does not have any immediate benefits. Even though there may 
be no immediate benefits but your participation is likely to help us find the answer to 
research question (Assessing the determinants of cardiovascular diseases among rural 
adults of Joe Gqabi District: Eastern Cape) and provide strategic ways to manage, 
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influence policies. There may also not be societal benefits at this stage of the research but 
future generations are likely to benefit from your participation.  
 
Protection of Confidentiality 
The information that we collect from this research project will be kept confidential. 
Information about you that will be collected during the research will be put away an no 
one but the research team (researcher, supervisor and the ethics committee) will be able 
to see it. Any information about you will have a number instead of a name. only the 
researcher will know what your number is and only the information you gave consent to 
will be revealed. Data questionnaires will be stored in a lockable cabinet and safe 
electronic software will be used as analysis.  
 
Contact information 
 
If you have any questions or concerns about this study or if any problems arise, please 
contact Dr. C. R. Sewani-Rusike at Walter Sisulu University at 047 502 2773  If you have 
any questions or concerns about your rights as a research participant, please contact  
HSRC Research ethic Committee’s toll free number 0800 212 123. 
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Appendix 5: Consent Form 
 
I hereby agree to participate in the research on “Assessing     risk factors of 
cardiovascular diseases among rural adults of Joe Gqabi District: Eastern Cape. 
 
        Please initial Box 
 
1. I confirm that I have read and understand the information 
sheet for the above study and had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free 
to withdraw at anytime without giving reason 
 
3. I agree to take part to take part in the above study     
 
4. I understand that the information I provide will be stored  
electronically and will be used for research purposes now and later stage 
 
 
           
Signature of participant    Date 
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Appendix 6: RESEARCH QUESTIONNAIRE 
 
Research Question: “Assessing     risk factors of cardiovascular diseases among rural 
adults of Joe Gqabi District: Eastern Cape. 
Purpose of the study:  
 
Code number:     Today’s date:    
Facility Name:     
 
 
AGE         GENDER 
 
ANTHROPOMETRIC MEASURES 
Weight Height Waist BMI Blood 
Pressure 
Blood 
Glucose 
      
 
Are you currently (check only one) 
Married Separated Divorced Widowed Single Cohabitation 
 
Please circle the highest year of school completed  
1 2 3 4 5 
(primary) 
7 8 9 10 11 12 
(high school) 
College, FET, 
Under graduate 
Post 
graduate 
(Honours) 
Masters PhD (other) 
male  
female  
How old are you?  
BACKGROUND and ENVIROMENTAL 
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Source of Income: Are you currently (circle answer) 
Employed 
 
Not Employed Self employed Government 
Subsidy 
Other 
(specify) 
 
Housing: Do you stay in a  
Mud 
Structure 
house 
 
Urban rural Shack Urban Morden 
House 
Other 
(specify) 
 
Stress: Have you experienced any of the following events in the past 6 
months (circle if applicable) 
Death of spouse Minor illness/injury/surgery Illness in the family 
Death of a family member Marriage Sexual difficulties 
Divorce/Separation Dismissal from work Pregnancy 
Marital reconciliation Retirement Personal difficulties at work 
Jail term Death of a friend Minor violations of the law 
Change in financial state Family or relationship disputes Change in work responsibilities 
 
How often do you feel any of the following? 
Anxiety Not at all A little Quite a bit Extremely 
Worry Not at all A little Quite a bit Extremely 
Sudden Feeling of panic Not at all A little Quite a bit Extremely 
Inability to control breathing  Not at all A little Quite a bit Extremely 
Accelerated heart rate when 
upset 
Not at all A little Quite a bit Extremely 
Recurrent feeling of unease Not at all A little Quite a bit Extremely 
 
Do you have feelings of: 
Sadness Not at all A little Quite a bit Extremely 
Depression Not at all A little Quite a bit Extremely 
Hopelessness Not at all A little Quite a bit Extremely 
Apathy Not at all A little Quite a bit Extremely 
Loneliness Not at all A little Quite a bit Extremely 
Lack of interest in social 
interaction 
Not at all A little Quite a bit Extremely 
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Are you easily  
Angered Not at all A little Quite a bit Extremely 
Frustrated Not at all A little Quite a bit Extremely 
Feel resentment Not at all A little Quite a bit Extremely 
Hostility towards others Not at all A little Quite a bit Extremely 
Frequently irritable Not at all A little Quite a bit Extremely 
 
 
 
 
Exercise: How often do you engage in exercises (please circle one score) 
Rarely or never 1-2 times each week 3 -4 times each week 5 or more times a week 
 
Smoking: What is your current Cigarette smoking habit 
I do not 
smoke 
Ex smoker Smoke less than 1 
pack a day 
Smoke about a 
pack a week 
Smoke 2 or more 
packs a day 
I do not 
smoke 
cigarettes, 
but I use 
other 
tobacco 
products 
 
Alcohol use: 
I do not 
drink 
Ex drinker Drink less than 
once  a day 
 Drink twice a 
week 
Drink more than 
three times a week 
 
Diet 
How often do you usually eat fried 
foods 
Less than once a 
week 
1-2 times a 
week 
3-6 times a 
week 
Everyday 
How many of serves of bread, past, 0-1 serves daily 2 serves daily 3 serves 4 or more 
BEHAVIORAL 
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rice, potatoes or other starchy foods 
do you have a day 
daily serves daily 
How many servings of sweet foods 
like cakes, buiscuts, chocolates ect do 
you eat a day 
Usually none 1-2 serves 
daily 
More than 
2 serves 
daily 
 
How many teaspoons of sugar do you 
consume daily in hot drinks, added to 
food etc. 
0-3 4-6 7-9 10 or more 
How often do you usually eat fish Rarely 1-2 times a 
week 
3-6 times a 
week 
Everyday 
How many pieces of fruit do you 
usually eat  a day 
Usually none 1-3 pieces 
daily 
4 or more 
pieces 
 
How many serves of 
vegetables(exclpotatoes) do you 
usually eat a day 
Usually none 1-3 pieces 
daily 
4 or more 
pieces 
5 or serves 
daily 
How many cups of coffee do you 
usually drink a day 
Usually none 1-3 cups daily 4 or more 
cups 
5 or cups 
daily 
How much soft drinks do you consume 
on average 
Less than 500ml per 
week 
1-2 litres per 
weeks 
3-4 litres 
per week 
5 or more 
litres per 
week 
How much water do you drink a day 0- 500ml 500ml-1.25 
litres 
More than 
1.25 litres 
 
 
 
 
Family History: What type of CVD were you told to be suffering from? 
None                                                                                                                    Yes /No
Hypertension                                                                                                         Yes /No
CVA (stroke)                                                                                                        Yes /No 
Cardiac Failure                                                                                                       Yes /No 
Ischaemic/Coronary Heart 
Disease                                                                    
Yes /No 
Congenital Heart Disease                         Yes /No 
Peripheral Vascular  Disease                   Yes /No 
Rheumatic Heart Disease                         Yes /No 
Cardiomyopathy                                        Yes /No 
DIAGNOSIS & BIOLOGICAL 
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Other (specify)                                           Yes /No 
Do not know                                           Yes /No 
 
Is/was there anybody in your family with a history of CVD?(circle all 
appropriate) 
None Yes    / No 
Father Yes /No 
Mother Yes /No 
Grand mother/Father Yes /No 
Brother/Sister Yes /No 
Other Yes /No 
Don’t Know Yes /No 
If yes,  what CVD did he/she/they suffer from (circle all appropriate) 
None                                                                                                                    Yes / No
Hypertension                                                                                                         Yes /No
CVA (stroke)                                                                                                        Yes /No 
Cardiac Failure                                                                                                       Yes /No 
Ischaemic/Coronary Heart 
Disease                                                                    
Yes /No 
Congenital Heart Disease                         Yes /No 
Peripheral Vascular  Disease                   Yes /No 
Rheumatic Heart Disease                         Yes /No 
Cardiomyopathy                                        Yes /No 
Other (specify)                                           Yes /No 
Do not know                                           Yes /No 
 
Have you in the past been diagnosed with: 
Hypertension 
 
Yes No 
 
If yes : Which statement best describes your Blood Pressure 
Normal or low  
Borderline  
High  
I’m not sure  
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Have you in the past been diagnosed with: 
Diabetes 
 
Yes No 
 
If yes : Which statement best describes your Diabetes 
Normal or low  
Borderline  
High  
Im not sure  
 
Which statement best describes your Total Cholestorol 
Normal or low  
Borderline  
High  
I’m not sure  
 
END OF QUESTIONNAIRE: THANK YOU FOR YOUR TIME 
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Ikhowdi yomthathi nxaxheba:    
Umhla wodliwano ndlebe:     
Igama  lendawo:     
 
 
IMINYAKA        ISINI 
 
ANTHROPOMETRIC MEASURES 
Weight Height Waist BMI Blood 
Pressure 
Blood 
Glucose 
      
 
Ingaba  (Khetha ibenye kwezilandelayo) 
Utshatile Nisohlukene 
okwethutyana 
Waqhawuka 
umtshato                                    
Ungumhlolo/umhlolokazi                              Awutshatanga Uyahlalisana 
 
Elona nqanaba lemfundo eliphezulu oliphumeleleyo? 
1 2 3 4 5 
(Amabanga 
aphantsi) 
7 8 9 10 11 12 
(Amabanga aphakathi) 
IDegree okanye 
iCollege 
Post 
graduate 
(Honours) 
Masters PhD (other) 
Ingaba uyasebenza ngoku? 
Ewe- 
kumsebenzi 
osisigxina 
 
Hayi andisebenzi                                                     Ewe-Ndiziqeshile Government 
Subsidy 
Enye 
 
Uyindonda  
Ungowasetyhini  
Mingaphi iminyaka yakho?  
INKCUKACHA ZENTLALO 
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Loluphi udidi lwendlu ohlala kuyo? 
Yindlu yodaka 
yasezilalini                                           
Ezizindlu zalamaxesha 
zasezilalini           
Ityotyombe 
/umkhukhu                                                
Indlu enkulu 
yasedolophini                           
Enye 
 
Unxinezelelo lwenqondo (kwenyanga zintandathu zidlulileyo) 
Ubujewe ngumilngane Izigulo 
zexeshana/wenzakala/uhlinzo 
Izigulo zezizalwana 
Ubhuje;we lilungu losapho Umtshato Ingxaki kwezosondo 
Waqhawuka umtshato Wangxothwa emsebenzini Ukhulelwa 
Marital reconciliation Umhlala phantsi Ingxaki emsebenzini 
Wakhe wabanjwa Ubhujelwe ngumhlobo Ukungsoli iso komthetho 
Uthitsho kwisomo sezemali Ukungaboni ngasonye 
nezizalwane 
Utshinstho emsebenzini 
 
Ingaba uziva kangaphi ezi zilandelayo 
unxunguphalo Ayikho Kancinane Kancinci Ngamandla 
ixhala Ayikho Kancinane Kancinci Ngamandla 
Uzive usoyika  Ayikho Kancinane Kancinci Ngamandla 
Ukungakwazi ukuphefumla  Ayikho Kancinane Kancinci Ngamandla 
Intliziyo ebetha ngamandla xa 
ucaphukile 
Ayikho Kancinane Kancinci Ngamandla 
Umane uziva ungenelisekanga Ayikho Kancinane Kancinci Ngamandla 
 
Ukhe umane uziva: 
Ungonwabanga Ayikho Kancinane Kancinci Ngamandla 
Unxinrzelelo oulanamndla Ayikho Kancinane Kancinci Ngamandla 
Uphelelwa lithemba Ayikho Kancinane Kancinci Ngamandla 
usizi Ayikho Kancinane Kancinci Ngamandla 
Umva ndedwa Ayikho Kancinane Kancinci Ngamandla 
Ungakwazi ukkunxibelelana 
nabantu 
Ayikho Kancinane Kancinci Ngamandla 
 
Ingaba uyakhawuleza ukuba nazo ezi zilandelayo 
umsindo Ayikho Kancinane Kancinci Ngamandla 
nxunguphele Ayikho Kancinane Kancinci Ngamandla 
Uzive usonyanya Ayikho Kancinane Kancinci Ngamandla 
Ubutshaba kwabanye abantu Ayikho Kancinane Kancinci Ngamandla 
Soloko uziva udikiwe Ayikho Kancinane Kancinci Ngamandla 
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Ukuzilolonga: Ukhe uwulolonge umzimba? 
Zange Kanye ukuya kwisibini 
ngeveki 
Kathathu-ukuya kwisine 
ngeveki 
Kahlanu nangaphezulu 
ngeveki 
 
Ukutshaya: Zingaphi  icigareti / izoli ozitshayayo ngosuku? 
Anditshayi Ndayeka Ndisebenzisa 
ngaphantsi kwe 
paketi enye 
ngosuku 
Ndisebenzisa 
ipaketi ibenye 
ngeveki 
Ndisebenzisa I 
paketi ezimbini 
nangaphezulu 
ngeveki 
Anditshayi 
cigariti 
kodwa 
ndisebenzisa 
mhlobo 
wumbi 
Ukutya 
Uyitya kangakannai inyama 
egcadiweyo 
Less than once a 
week 
1-2 nge veki 3-6 times a 
week 
Mihla yonke 
Usitya kangakanani isonka, rayisi, 
amazambane okanye nakuphi ukutya 
okune sitatshi ngosuku.   
0-1 serves daily 2 serves daily 3 serves 
daily 
4 or more 
serves daily 
Zingaphi ii switsi, kayiki, 
amaqebengwane ozityayo ngosuku 
Nakanye 1-2 nge veki More than 
2 serves 
daily 
 
Mangaphi amatisipuni eswekile 
owathathayo ngosuku xa uphunga 
iziphungo ezishushu okanye. 
0-3 4-6 7-9 10 okanye 
nangaphezulu 
Uyangaphi intlanzi ngosuku Rarely 1-2 nge veki 3-6 times a 
week 
Mihla yonke 
Mangaphi amaqekeza eziqhamo 
owatyayo ngosuku 
Nakanye 1-3 pieces 
daily 
4 or more 
pieces 
 
Zingaphi izitya zemifuno ozityayo 
ngosuku (ngaphandle 
kwamazambane) 
Nakanye 1-3 pieces 
daily 
4 or more 
pieces 
5 or serves 
daily 
Zingaphi iikomityi zee kofu oziphunga 
ngosuku 
Nakanye 1-3 cups daily 4 or more 
cups 
5 or cups 
daily 
INDLELA ZOKUZIPHATHA  
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Iziselo ezihlwahlwazayo uzisela 
kangakanani 
Less than 500ml per 
week 
1-2 litres per 
weeks 
3-4 litres 
per week 
5 or more 
litres per 
week 
Uwasela kangakanani amanzi ngosuku 1- 500ml 500ml-1.25 
litres 
More than 
1.25 litres 
 
 
 
 
Sesiphi isigulo sentliziyo owaxelelwa ukuba unaso kwezi zilandelayo 
(ukuba asisinyanga, bhala zonke) 
Ayikho                                                                                                                 Ewe / Hayi
High-high                                                                                                     Ewe   / Hayi
CVA (stroke)                                                                                                        Ewe   / Hayi 
Cardiac Failure                                                                                                       Ewe / Hayi 
Ischaemic/Coronary Heart 
Disease                                                                    
Ewe   / Hayi 
Congenital Heart Disease                         Ewe / Hayi 
Peripheral Vascular  Disease                   Ewe   / Hayi 
Rheumatic Heart Disease                         Ewe / Hayi 
Cardiomyopathy                                        Ewe / Hayi 
Enye (chaza)                                           Ewe / Hayi 
Andazi                                           Ewe   / Hayi 
 
Ingaba ukho umntu kwizizalwane zakho onesifo okanye owayenesifo 
sentliziyo? 
Akekho Ewe   / Hayi 
uTata Ewe   / Hayi 
uMama Ewe   / Hayi 
Utatomkhulu/makhulu                                      Ewe / Hayi 
Umnakwenu/udadewenu                                  Ewe / Hayi 
Omnye umntu                                                         Ewe / Hayi 
Awunalwazi Ewe   / Hayi 
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Ukuba impendulo yakho ngu ewe, waye nesiphi isigulo kwezi? 
(ukuba asisinyanga, zibhale zonke) 
Ayikho                                                                                                                  Ewe / Hayi
High-high                                                                                                       Ewe   / Hayi
CVA (stroke)                                                                                                        Ewe   / Hayi 
Cardiac Failure                                                                                                       Ewe / Hayi 
Ischaemic/Coronary Heart 
Disease                                                                    
Ewe   / Hayi 
Congenital Heart Disease                         Ewe / Hayi 
Peripheral Vascular  Disease                   Ewe   / Hayi 
Rheumatic Heart Disease                         Ewe / Hayi 
Cardiomyopathy                                        Ewe / Hayi 
Enye (chaza)                                           Ewe / Hayi 
Andazi nto                                           Ewe / Hayi 
 
Wena wakhe waxelelwa ngoGqirha ukuba:  
unesifo se high- 
high? 
 
Ewe Hayi 
 
Ukuba uphendule ngo Ewe: Yeyiphi incukhaca ecaza isimo sakho se Blood 
Pressure 
Iphantsi/ Ikwisimo esilungileyo  
Iphakathi/Isecicini  
Iphezulu  
Andazi nto  
 
Ingaba wakhe waxelelwa ngoGqirha ukuba:  
unesifo seswekile 
ngaphambili? 
 
Ewe Hayi 
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Ukuba uphendule ngo Ewe: Yeyiphi indlela ethe ncakasana ecacisa isimo 
seswekile kuwe 
Asezantsi/ Akugele  
Iphakathi/Isecicini  
Aphezulu  
Andiqinisekanga  
 
Yeyiphi indlela the ncakasana ecacisa isimo sama futha emzimbeni kuwe: 
Asezantsi/ Akugele  
Iphakathi/Isecicini  
Aphezulu  
Andiqinisekanga  
 
ISIPHELO SECHUNGECHUNGE LWEMIBUZO:    ENKOSI NGOKUTHABATHA 
INXAXHEBA 
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Ingcazelo ethe vetshe malunga nolu phando nzulu 
 
Uyacelwa okkuba uthabathe inxacheba kuphando nzulu olwenziwa phantsi 
kolawulo luka Dr. B. Bongsha kwi Dyinivesiti yase Walter Sisulu University. 
 
Olu luphando oluzama ukunceda abaqulunqi bemithetho, abacwangcisi 
besebe lezempilo kwakunye noluntu lweMpuma Koloni ngokubanzi, 
ukuqwalasela nzulu imiceli mingeni ekulweni nezifo zentliziyo. Ukuthatha 
inxaxheba nentsebenziswano yakho koluphando luzakunceda ekuveliseni 
indlela ezingcono zokukhusela kwa nokulawula izifo zentliziyo kweliphondo 
nakwisizwe ngokubanzi. 
 
 
Inxaxheba Enganasinyanzeliso 
 
Inxhaxeba yakho kolu phando nzuli alisosinyanzeliso, yaye unelungelo 
lokukhetha okuba uyakuthanda okanye awukuthandi ukuthatha inxaxheba. 
Nokuba ukhethatha ukuthatha inxaxheba esibhedlele okanye eklinik 
ayenzimahluko lonto. Yaye unalo ilungelo lokuguqula ingqondo naiphi ixesha 
ufuna noba ubusele uvumile, awuyi kujeziswa ngalonto.  
 
Ukuba uyavuma ukuzibandakanya noluchungecunge, kubalulekile wazi into 
yokuba izakuthatha imizuzu engamashumi amathathu apho sijongene nolwazi 
lwakho ngezifo zentliziyo. Uyacelwa ke ukuba uphendule ngokunyanisekileyo/.  
 
Ungcipheko nokungahlaliseki kakuhle 
Ngethuba uthatha inxaxheba kolu chungechuge lwemibuzo amathuba 
okukubeka elungciphekweni nokungonwabi awekho. Oluchungechuge 
lwemibuzo lusetyenziwe pha lujongana nendlela yokuziphatha yaye alunakuze 
lubanglele ukungonwabi.  
 
Amaqithithi akhoyo 
Kungelishwa lokuba olu phando zulu alunawo amaqithithi akhawulezileyo 
afumanekayo. Nangona engekhoyo amaqithithi, ulwazi osinika lona 
luzakincedisa ekufaneni impedulo zophando lokuba zeziphi indlela 
zokuziphatha ezibeka emngciphekweni, kunye nonobangela bezifo entliziyo 
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kubantu abadala abathetho yesiXhodsa kumnandla wase Joe Gqabi.  Yaye 
kungakho nokuncedala kwesizwe siphela, yaye nesizukulwana esilandelalo 
singaxamla kwimpendulo zakho 
Ukhuseleko Lolwazi 
 
 Zonke incukacha eziqokelelweyo kolu phando nzulu zoo ngcinwa 
ngokkufihlakeleyo. Yaye nencukacha ngawe ziyo ngicwa ngokufihlakeleyo 
ngaba qhubi bodliwano ndlebe. Ulwazi ngawe luyoba nee nomboro endaweni 
yegama lakho, yaye ngumqubi dliwano ndlebe yedwa uyokuyazi inomboro, 
xeshikweni kufuneka kukhutshwe ulwazi, lwakhukutswa ngemvume yakho.  
 
Uchungenchunge lwemibuzo iyakugcwinwa ekhabhathini etixhwayo naleyo 
ifakwe kwi computer iyakugcinwa ngoku fihlakelyo.  
 
Nxubelelana nathi 
 
Ukuba uthe wanembibuzo Kanye kukho into ongayiqondiyo malunga nolu 
gcungecunge lwemibuzo, uyacelwa ungoyiki ukuqakamishelana nathi (I 
Dyunivesiti yase Walter Sisulu) ngoko mxeba kule nomboro 083 683 8767. 
Kananjalo ukuba unganemibuzo maunga namalungelo akho nje ngo mthati 
nxaxheba ungatsalela kule nomboro ingahlawulelwayo ye HSRC Research 
ethic Committee ethi 0800 212 123. 
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Appendix 5: Isivumelwano 
Oku kubonakalisa ukuba ndiyavuma ukuba yinxalenye okanye ukuthatha inxaxeba 
kuncungechuge lwemibuzo on “Assessing     risk factors of cardiovascular diseases among 
rural adults of Joe Gqabi District: Eastern Cape. 
 
        Bekaba u “X” 
1. Ndiyaqinisekisa ukuba yonke into ndiyayiqonda kwaye ndizifundile  
zonke incukaca. 
2. Ndiyaqonda kwaye ndivuma ukuba andinyazeliswanga ukuba  
ndithtathe inxaxeba, yaye ndingayeka naninina ndifuna ngaphandle 
kwesizathu. 
 
3. Ndiyavuma ukuthabatha inxaxeba koluphando nzulu    
 
4. Ndiyaqonda ukuba kokne endikucazile kuyogcinwa yaye kusetyezise 
kwangoko okanye ngelinye ixesha 
 
 
           
Siginitsha yomthati nxaxeba    Usuku 
 
